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Purpose: The increasing use of MRI alongside CT images has brought about
growing interest in trying to determine radiation attenuation information based
on MR images only. The primary aim of this thesis is, therefore, to determine
what head tissue compartments need to have separate HU values in order to
obtain su cient RT planning accuracy. This can serve as input for an MR-based
classification thus enabling pseudo-CT generation in an MR-only RT workflow.
Methods: To achieve this target, flattened (stratified) CT images (fCT) were
generated and compared to the original CT images. Mean (ME) and mean
absolute (MAE) errors were used for the fCT quality assessment, as was dose
comparisons. 70 CT-based RT plans were generated and the dose distributions
compared to those obtained when using the di erent fCT versions in place
of the original CT images. The dose agreement was assessed using DVH and
1%/1mm gamma analysis.
Results: The lowest MAE of 59.63HU was calculated for an fCT8 version.
DVH analysis showed low di erences in the range between 3% (water-filled fCT)
and 0.05% depending on the tissue stratification of the fCT version. 1%/1mm
gamma analysis correctly identified plans where insu ciently fine-grained tissue
classification was the main reason for dose discrepancy. The best RT planning
accuracy was obtained for the fCT5 with segmented air cavities, fat, water-rich
tissue, spongy, and compact bone, and for the fCT8 where also the brain tissue
was stratified.
Conclusions: The small di erences in dose accuracy between CT and fCT
images shows the feasibility of using MR-only RT planning for the brain.
Nonetheless, other aspects of the MR-only workflow, such as patient positioning,
as well as the impact of e.g. the surgical incisions in the skull should be subject
to further research.
Keywords: radiotherapy, MR-only, brain tumour, CT, MRI, tissue strati-
fication, image segmentation, pseudo-CT, dose comparisons,
gamma analysis, DVH analysis, RT planning
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11 Introduction
CT imaging on its own has been used for decades in the radiotherapy (RT) planning
process. Lately, MR imaging has grown in importance due to the superior soft-
tissue contrast which allows better contouring of the tumour and organs at risk
(OARs) to be avoided [1, 2]. The recent introduction of MRI has resulted in growing
interest in trying to determine radiation attenuation information based on MR
images only. Since the MRI signal rather correlates with proton density, it does not
contain information about electron density of tissue compartments. The electron
density is an important parameter in intensity modulated radiotherapy (IMRT) as
it represents the ability of the tissue to attenuate X-rays in the form of external
radiation beams generated by a linear accelerator (LINAC) [3]. Hence, the use of a
computed tomography (CT) is still required in current clinical practice due to the
linear relation, and therefore, easy conversion of Hounsfield units (HU) to information
about the electron density of tissue. A so-called CT-density or -calibration tables
are usually employed in this conversion process [4].
Acquisition of additional CT scan, however, negatively influences the patients
(increased radiation burden) as well as clinical facilities, where every single additional
step introduced into the RT treatment workflow increases workload. This in turn
results in longer RT treatment-planning times and higher financial costs [1, 3, 4,
5]. Furthermore, a rigid MR-CT image registration, which introduces additional
spatial uncertainties, is required for transferring the MRI-based organ and tumour
delineations to the CT image. The mean cranial registration error was estimated
as approximately 2mm with similar values for other body sites. The acquisition of
multiple image sets also introduces errors stemming from patient repositioning and
anatomical changes as the time between scanning sessions may be counted in several
days or even weeks [1]. All these issues related to increased workload and CT-MRI
registration errors resulted in raised focus on research into simplified RT planning
workflow using only the MR images that are in this workflow further utilised for the
generation of so-called pseudo-CT (pCT) images [6]. These synthetic CTs entirely
substitute the need for acquisition of additional CT scans, and therefore it allows
decreasing both the workload and patient burden [5].
Multiple algorithms for pCT generation exist, with varying prediction accuracy
as well as computational costs. The computational time is an important param-
eter especially in clinical practice where is usually required the availability of the
accurate pCT within short reconstruction time [2] in order to allow the potential
MRI reacquisition during a single imaging session. Each of algorithms for pCT
prediction has its shortcomings originating mostly from the MR characteristics. MR
imaging is not a convenient method for compact bone visualisation, and therefore,
also for their segmentation as both, compact bones and air possess very low T2
constants causing the magnetic spins to dephase quickly. Short T2 relaxation times
result in low-intensity in MR image voxels, and it is, therefore, not possible to easily
distinguish bones from air cavities. The low contrast between voxels is a particular
issue when one needs to separate air cavities from surrounding bones [1]
The MR-only RT workflow for prostate cancer treatment has been already granted
FDA approval [7] which is the essential step for its introduction to clinical practice.
This MR-only solution known as the Magnetic Resonance for Calculating Attenuation
(MRCAT) has been developed by Philips Healthcare. The MRCAT is based on a
model-based classification method using mDixon MR imaging data. Here, the output
is the pCT image encompassing five tissue segments that are the background air, fat,
water-rich tissue, spongy bone, and compact bone. These compartments are filled by
corresponding bulk HU values [8]. This technique of average HU value assignment
to the segmented tissue labels is one of the characteristics of so-called voxel-based
methods for pCT image generation.
The goal of this study is to investigate the feasibility of MR-only radiotherapy
using the pCT images generated through similar voxel-based approach as it is currently
done in the case of MRCAT. The primary aim of this thesis is, therefore, to find out
what tissues need to be segmented based on the MR image in order to get a su cient
dose accuracy. Several studies were published proposing that MR-only bulk density
based photon RT should be feasible for tumours located in the brain with dosimetric
accuracy in a range of up to 2% [5, 9, 10]. Nonetheless, these studies mostly used
pCT images with dual or triple bulk HU assignment for water, bone and air cavities
respectively. This observation has further encouraged the research presented in this
study where multiple versions of pCT images encompassing up to eight segmented
compartments (bulk HU values) are used in order to find the stratification expressing
the best dosimetric agreement with CT-based RT plans.
The first stage of this work is focused on generating of flattened CT through CT
and MR image segmentation. These fCT images served as the substitution for the
real MR-only based pCT images. The next steps are devoted to the generation of
radiotherapy plans that were calculated on real CT images with varying tumour
positions and recalculated on multiple versions of fCT images. The geometrical
agreement and dose accuracy were assessed for all fCTs in comparison with real CT
as the reference. The summary of results is shown and discussed in corresponding
sections, and the fCT with the best dose accuracy is identified. This will allow an
optimal design of the MR scan sequence that best visualises the tissues to be classified
for the pCT brain image. Moreover, the classification methods used may serve as
a starting point for the pCT generation. The work presented in this study will
thereby enable further research into the introduction of MR-only radiation therapy
for treatment of brain tumours into the clinical practice.
32 Background
2.1 Brain cancer overview
Cancer is one of the leading causes of death worldwide [11]. It is the group of diseases
characterised by abnormal cell growth forming neoplasms that can potentially spread
or invade to other body sites. Neoplasms occurring in intracranial tissues are
collectively termed as brain tumours. Even though the incidence of cancer in central
nervous system (CNS) is relatively low (less than 1% in Europe in 2012) [12], more
than 120 brain tumour types have been identified according to the classification of
the World Health Organisation (WHO) [13].
2.1.1 Brain tumours
There are two dominant groups of brain tumours. One group consists of benign
tumours that do not invade surrounding and distant tissues. The second group
constitutes cancerous or malignant neoplasms which can be further classified into
primary and secondary tumours. Secondary tumours are represented by metastases
that have expanded from primary cancers located in other parts of the body. The
incidence of brain metastases is higher in comparison with primary malignant tumours.
Secondary tumours arise mostly from lung, breast, melanoma, renal, or colon cancer
and represent 40% of neoplasms diagnosed in the cranium [14]. Primary cranial
tumours, on the other hand, originate directly from cranial cells and benign neoplasms
and are therefore included in this category as well [15]. The WHO classification of
CNS tumours is based on their histology as neoplasia usually arises from particular
cell types (e.g. astrocytes, glial cells). The categorization of brain tumours is in
addition to the cellular parameters further extended based on molecular parameters
of particular tumour types [13]. The most common primary brain tumours include
(in order of frequency) gliomas (50.4%), meningiomas (20.8%), pituitary adenomas
(15%) and nerve sheath tumours (8%) [16].
Brain tumours are further classified by grades (I-IV). The purpose of using
tumour grades is to simplify the search for the most appropriate treatment strategy
and method as the grading identifies the structure and aggressivity level of the
tumour. For instance, the vast majority of benign tumours belong to the grade I
category. Tumours for which already exists the high risk of malignancy and can,
therefore, possibly invade and destroy surrounding cells and tissues are classified by
grade II. Neoplasms graded with III or IV are already malignant, and their prognosis
is not widely defined as it highly depends on tumour location and accordingly by
treatment and removing possibilities [17].
Exact causes of neoplasia in the brain are unknown. There have been identified
risk factors such as ionising radiation, immune function, inherited susceptibility,
metals and neurocarcinogens [18]. Reported inconsistency and sparsity of root causes
for brain cancer are due to small patient cohorts and the variation in objectives of
clinical trials. The small sample sizes can be explained by in general low survival rates,
relative rareness of brain tumours and low participation of patients in individual
studies [18, 19]. An overall five-year survival rate of 25.3% was reported for primary
4brain tumours. However, this outlook varies significantly according to diagnosis
and patient age. For instance, a five-year survival rate of only 3.3% was reported
for the most aggressive and at the same time the most common malignant primary
brain tumour, glioblastoma multiforme (GBM). In the case of lower grade gliomas,
such as astrocytoma, lymphoma or malignant glioma five-year survival rates are
lower than 40%, whereas more optimistic rates exceeding 70% were reported for
oligodendrogliomas, ependymomas and pilocytic astrocytomas. In general, five-year
survival rates tend to decrease with higher age of the patient [18]. The initial diagnosis
of brain tumours is usually accomplished by medical imaging such as MRI. The
appearance of selected brain tumour on MR images is shown in figure 2.1.
(a) (b) (c)
(d) (e) (f)
Figure 2.1: Examples of primary and secondary brain tumours and comparison of
their appearance in T1 (a-c) and T2 (d-f) MR images. Primary glioblastoma after
surgery (a, d) and secondary tumours (metastases) originating from renal (b, e) and
lung (c, f) carcinomas without prior surgery.
2.1.2 Radiotherapy and other treatment options
Treatment of brain tumours may comprise a combination of radiotherapy, surgery,
and chemotherapy. Nevertheless, the use of chemotherapy in brain cancer treatment
is not a straightforward option as the hematoencephalic barrier prevents some drugs
entering the brain [20]. Besides surgery, radiation therapy is considered to be the
most e ective treatment for brain tumours [21]. The primary aim in radiotherapy
is to deliver the prescribed dose to the tumour while minimising the dose delivered
to the adjacent tissues [15]. The advancement of intensity-modulated radiotherapy
5(IMRT) using external beam delivery has substantially reduced the limitations of
conventional RT methods [22]. This thesis is, therefore, primarily focused on the
MR-only RT solution utilising IMRT delivery technique that is increasingly being
used at the expense of conventional RT methods.
The fractionation and prescribed doses in RT rely heavily on the diagnosis as well
as on the location and volume of the targeted lesion. Fractionated treatments are used
in the event of cancerous tumours, whereas benign neoplasms are usually treated with
a single RT session [23]. One of the issues relevant to primary malignant tumours is
that invasive surgery is not curative even in grade II tumours, due to their infiltrative
character. Nevertheless, the extent of tumour resection is of particular importance for
disease prognosis. Consequently, postoperative or standalone radiotherapy remains
an essential part of the majority brain tumour treatments [19]. In the case of
metastatic lesions, a whole brain radiotherapy (WBRT) with the possibility of local
dose boost can be applied after surgery [14]. However, standalone or postoperative
stereotactic radiotherapy without WBRT can be employed in the secondary brain
tumour treatment as well [24].
2.2 Radiotherapy simulation
Radiotherapy simulation process consists of multiple phases. The first phase comprises
determining the diagnosis and selection of treatment strategy. The RT simulation
continues with patient positioning and fixation for image acquisition which are to
be unchanged throughout entire RT process. The patient is placed into comfortable
and reproducible position (usually supine). However, another positioning is possible
as well [14]. There are currently two basic types of fixation devices. The first and
the most commonly used fixation device is a so-called thermoplastic mask. Another
possibility is to use a fixation frame which is rigidly mounted to the patient head or
skull using special bolts. The fixation frame provides higher positioning accuracy
and further eliminates the risk of inter- and intra-fractional patient movements
[25]. However, the use of thermoplastic masks (frameless SRT/SRS) is increasingly
favoured even in the case of highly focused SRS and SRT treatments as novel frameless
solutions provide su cient positioning accuracy, superior patient comfort and is
convenient for RT workflow in general [24].
The next stage of RT simulation is the collection of medical images. The acquisi-
tion of both, CT and MR images is the fundamental step in standard RT workflow,
while only the MR scans are collected when the MR-only workflow is used. All
the images should be acquired with the patient placed in the treatment position
including all the positioning and fixation devices. These images are then registered
and used as a basis for target and OAR delineation as well as RT planning in TPS
[25]. MR and CT scanners with a wide bore and flat patient couches allowing better
positioning can be employed in the RT simulation process [14].
62.2.1 Target volumes and organs at risk
Target volumes There exist three essential target volumes (TV) that are taken
into consideration upon the radiotherapy planning. These volumes are the gross
tumour volume (GTV), the clinical target volume (CTV) and the primary target
volume (PTV) [14]. The concept of these volumes is shown in figure 2.2.
GTV CTV PTV
Treated volume
OAR
Figure 2.2: Schematic of a treated volume and organ at risk (OAR) located in the
irradiated/patient volume. TV covers a primary target volume (PTV), a clinical
target volume (CTV) and a gross tumour volume (GTV).
Gross tumour volume (GTV) represents the tumour mass observed upon clinical
examination under anaesthesia or noninvasively by imaging. GTV always delineates
the tissue mass having the highest density of tumour cells [14, 21]. Tumour shape,
size and site may slightly di er depending on the employed imaging method, and
the oncologist, therefore, delineates the final GTV after detailed examination [26].
The GTV is usually entirely removed by the surgery if possible [14].
Clinical target volume (CTV) covers in addition to GTV the area of subclinical
microscopic disease or regional lymph node spread that are together with primary
tumour part to be removed [26]. Since these a ected areas are not detectable by
imaging methods, the CTV is usually defined based on histological examination.
Moreover, the selection of margin added to GTV is influenced by biological properties
of the tumour [21, 14]. The standalone CTV contour would in an ideal case be
su cient for the focusing and modulation of radiation beams upon the RT planning in
TPS. Nevertheless, changes in shape and size of internal organs, patient movements
(inter- and intra-fractional) and other uncertainties inherent in RT setup must be taken
into account in order to ensure full irradiation of the CTV [14, 26]. Consequently,
another margin is added to the CTV forming the primary or planning target volume
(PTV).
The PTV is then used for addressing dose prescriptions and beam targeting in
TPS in order to assure a delivery of prescribed dose to the entire CTV [14, 21]. The
treated volume (TV) also shown in figure 2.2 represents the tissue fraction that is
aimed to receive a specified dose and is enclosed by a particular isodose surface. This
may typically be the volume surrounded by the 95% isodose surface [14, 26]. The
7aim of modern conformal RT delivery techniques in connection with 3D treatment
planning is to optimise the RT plan in a way that TV precisely covers the PTV with
as low excess as possible. This assures a precise coverage of PTV while neighbouring
OARs are exposed to minimal irradiation [26]. The ratio between TV (95% isodose)
and PTV, which is also known as conformity index (CI), is commonly used in the
quality evaluation of RT plans.
Organs at risk Organs at risk (OARs) are critical normal tissue located in the
proximity or directly adjoining the PTV. These bodies do not contain malignant
cells and, consequently, they are not considered being treatment targets. Moreover,
such structures may often be susceptible to the ionising radiation. The goal of RT
plan optimisation ought, therefore, be to mitigate the risk of substantial morbidity
by minimising irradiation of OARs. The structures to be taken into account for RT
planning considerably vary in accordance with the treated anatomical site and the
location, shape and size of the PTV [26]. The accurate delineation of OARs is of
particular importance in the case of the brain where the irradiation may lead to
hormonal impairment, neurocognitive and neurological alterations as well as to deficits
in hearing and vision. Furthermore, precise delineation of OARs is indispensable for
the IMRT and inverse planning process [27].
The following structures were repetitively reported in literature to be OARs for
brain RT: lenses, eyes, cochleas, brainstem, pituitary gland, optic chiasm, nerves
and tracts [15, 27, 28, 29]. Moreover, the sparing of the hippocampus and other
structures has been studied as well in order to preclude the neurocognitive deficits
[5, 27, 30]. The recommended dose constraints to avoid adverse e ects for OARs in
the brain are shown in table 2.1. However, these limits are further decreased in the
event of treatments including single dose delivery fraction.
Table 2.1: Dose constraints for OARs in brain (RTOG, QUANTEC, [27])
Eyes Lenses Opticalpaths
Brain
stem
Pituitary
Gland Cochleas Brain
Dmax <54 Gy <5 - 10 Gy <54 - 55 Gy <54 Gy <50 - 60 Gy - <60 - 72 Gy
Dmean <35 Gy - - - - <45 - 50 Gy -
2.2.2 External beam radiation delivery
Linear accelerator (LINAC) machines are commonly used for a delivery of modern
external beam radiation therapy. The treatment head mounted on a rotatable gantry
is the core component of every LINAC. This head is equipped with X-ray target,
scattering foil, flattening filter, ion chamber, and secondary collimator. Photons of
a megavoltage (MV) range are produced upon a collision of accelerated electrons
with the X-ray target. This photon beam is firstly formed by the primary collimator
and then pass through the flattening filter which makes the X-ray intensity uniform
across the entire beam field. The role of the ion chamber is to monitor the field
symmetry, integrated dose and dose rate in monitor units (MU). The radiation beam
8is further shaped by the secondary collimator after passing through the ion chamber.
This dynamically movable collimator incorporates two pairs of jaws and the multileaf
collimator (MLC) which is the key component for the IMRT treatment delivery [25].
Figure 2.3 shows an example of the LINAC machine and the schematic image of how
the radiation beam comes out from the LINAC and is then formed by the di erent
treatment head layers and focused towards the target.
Electron beam
Flattening filter Primarycollimator
Secondary
collimator
Ion
chamber
X-ray target 
Target
Figure 2.3: Components of the LINAC treatment head and beam penumbra for
photon (X-ray) radiotherapy setup (left). An example of LINAC machine (right) -
courtesy of Varian Medical Systems (source: [31]).
92.2.3 Intensity-modulated radiotherapy
Intensity modulation Modern LINAC machines are equipped with a dynamically
controlled multi-leaf collimator (MLC) enabling dynamic modulation of the beam
radiation field. One of the fundamental MLC parameters is the number of leaf-pairs
where each pair is composed of two opposing leaves [32]. Every single pair of leaves
forms a sliding window. The width of such window changes as leaf-pair moves and so
that individual points in the patient volume are irradiated for di erent time periods.
These points, therefore, receive varying doses [26]. This is a fundamental principle of
the intensity modulation upon the RT treatment delivery. The MLC scheme and
principle of intensity modulation is shown in figure 2.4.
PTV
Figure 2.4: Intensity modulation by use of multi-leaf collimator (MLC)
Inverse planning A forward planning in 3D conformal RT provides a simple tissue
sparing with MLC shaped to cover only the PTV volume from multiple gantry angles
in order to achieve a uniform target coverage [14]. An inverse planning is, however,
way more sophisticated and computationally demanding process exploiting the entire
potential of RT delivery methods carried out with MLC-based LINAC. Several
inverse planning techniques exist, nevertheless, all of them employ certain a priori
known fixed parameters and specific free parameters to be optimised by the TPS.
The fixed parameters are usually the MV energy, a number of beams or arcs and their
directions while the remaining free parameters are the varying intensities delivered
from each of selected gantry angles [26]. The optimisation in inverse planning begins
with the specification of initial objective functions that constitute the starting points
of the optimisation process [33].
The set of initial objective functions consolidates information about desired
sparing of OARs and desired PTV coverage. The TPS then strives to achieve
these goals through optimisation which is based on minimising a cost function. A
choice of the cost function is crucial as its alternation while using the same inverse
planning method would result in a di erent result. The optimisation results can be
further modified by employing so-called biologically-based cost functions [26]. Apart
from high computational costs, the other drawback of inverse planning is that the
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impact of selected beam positions on the resulting dose distribution is unknown
until the plan optimisation has been accomplished. This usually results in a need
for several optimisation trials with di erent objective functions in order to obtain a
well-optimised plan [34]. Consequently, RT plan quality assessment strategies must
be used in order to determine whether the optimised solution is acceptable or not
[35].
Treatment delivery methods RT delivery methods taking advantage of the in-
tensity modulation are considered to be the state of the art of current RT. There are
two basic types of such techniques. The first method is an Intensity Modulated Ra-
diotherapy (IMRT) using a so-called step-and-shoot radiation delivery approach. The
step-and-shoot stands for the principle where the LINAC gantry stops in predefined
angle (beam direction), and the intensity modulation (shooting step) is carried out by
movement of MLC leaves in time. In IMRT treatment planning, the physicist usually
defines a number of beams and their directions based on intuition and experience.
Intensity profiles are then calculated by the use of the inverse planning [34].
The second and more recent method using intensity modulation and inverse
planning is a Volumetric Modulated Arc Therapy (VMAT) also known as SmartArc
(Philips) or RapidArc (Varian) [36]. VMAT is a novel RT delivery technique providing
highly conformal dose distribution and coverage within the PTV while sparing
surrounding OARs at the same time. It is possible to achieve a high degree of normal
tissues sparing due to the very steep dose gradients around the target volume. The
principle of VMAT lies in dynamic radiation delivery while both LINAC gantry
and MLC leaves are moving simultaneously during the treatment session [37]. Key
limiting factors in VMAT treatment delivery are machine parameters such as the
gantry rotation speed, the velocity of MLC leaves and a number of monitor units
(MU) per minute. Hence, the LINAC gantry has to move slowly when one wants
to achieve high-intensity modulation quality in all of the arc angles. The low speed
of gantry movement is crucial especially in the case of hypofractionated treatments
where high doses requiring high MU counts are delivered in a single fraction [32].
The VMAT technique is usually employed in SRT/SRS, and palliative treatments
of metastases or in cases, where the invasive surgery would pose a high risk of
permanent disability. The major advantage of VMAT is a reduction in treatment
delivery time while PTV coverage is comparable or superior to the IMRT [38],
with enhanced sparing of OARs. However, the optimisation of VMAT plan is a
computationally demanding process with high requirements on the computational
HW and the computation time is, therefore, longer in comparison with IMRT [39].
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2.2.4 Beam and arc arrangement
A basic coplanar arrangement where beams or arcs are allocated within a single
plane is the most commonly used RT setup in clinical practice [37]. Examples of
IMRT and VMAT plans with coplanar arrangements of beam or arcs are shown in
figure 2.5.
Figure 2.5: Examples of a coplanar arrangement of IMRT beams (left) and VMAT
full arcs (right). Here all beams or arcs are allocated in the single plane, and therefore,
the rotation of patient couch is not required.
However, novel LINAC machines are equipped with couches capable of dynamic
rotation during treatment delivery enabling non-coplanar beam directions or arc
trajectories that take advantage of the 4fi space [40]. It has been observed that
techniques using co-planar arc/beam setup irradiate contralateral OARs, such as the
optic nerves, in order to su ciently cover the PTV if it is located in the proximity
of those sensitive structures. This observation has brought forward the hypothesis
that techniques involving a non-coplanar beam setup might help to decrease doses
delivered into such OARs [41, 42]. For example, superior sparing of contralateral
optic paths has been reported while using the IMRT plans with non-coplanar beam
arrangement [39].
Moreover, a future use of 4fi non-coplanar radiotherapy could potentially improve
the outcome of glioblastoma-multiforme (GBM) treatment through extreme dose
escalation with very steep dose gradients surrounding the PTV [40]. This phenomenon
can be explained by the fact that non-coplanar arcs/beams supply an additional
degree of freedom for IMRT or VMAT planning and may allow for noticeable quality
enhancement in some cases of advanced RT plans [34]. The use of non-coplanar
beam/arc geometry, therefore, empowers further improvement in the OAR sparing
and the target coverage [34, 25]. Examples of IMRT and VMAT plans with non-
coplanar arrangements of beam or arcs are shown in figure 2.6.
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Figure 2.6: An example of a non-coplanar (left) arrangement of IMRT beams. Here,
the purple beam (forehead) is non-coplanar to the others. An example of use of
multiple non-copanar arcs in VMAT (right).
2.3 MR-only radiotherapy
The entire potential of modern RT delivery methods such as IMRT and VMAT can
be fully utilised only when the precise TV and OAR delineations are available. MR
imaging provides superior soft tissue contrast allowing for highly precise delineation
as compared to CT. Nonetheless, acquisition of CT image is still a key part of
conventional RT simulation workflow as it provides information about electron density
needed for dose calculations [43]. The patient positioning at treatment further takes
advantage from the superior bone contrast of CT image. This positioning is carried
out by registration of CT image with cone-beam computed tomography (CBCT) or
by digitally reconstructed radiograph (DRR) with the kV or MV image. MV images
are acquired directly by LINAC (portal imaging) or by an additional imaging device
installed on the LINAC or in the treatment room (kV imaging) upon the treatment
session with the patient positioned on the table [44].
2.3.1 MR-only radiotherapy workflow
Conventional RT simulation workflow consists of five stages that are CT and MRI
acquisition, image registration, structure contouring, and RT planning at the TPS
[1]. However, the patient repositioning and anatomical changes pose a risk of a lower
RT simulation accuracy as the time between imaging sessions can be counted in days
or weeks. Moreover, the registration error introduces a systematic spatial uncertainty
into the RT simulation process when transferring delineated structures from MRI to
the CT [43]. The dosimetric impact is increased when small structures are irradiated
or when the tumour is located in the proximity of sensitive organs. This could be of
particular importance in the case of small tumours found in the brain [45].
The MR-only approach allows reducing the entire RT simulation process into
three stages as there is no need for CT acquisition and CT-MRI registration step.
The comparison of the standard and MR-only workflow is shown by the diagram in
figure 2.7. MRI-only RT simulation would eliminate the systematic registration error
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which has been reported to be in the range between 2mm and 5mm depending on the
treated anatomy [43, 46]. Moreover, it would reduce the treatment-related financial
costs, and decrease the patient discomfort related to the acquisition of additional
CT scan. Adaptive RT treatment, where inter-fractional anatomical changes are
taken into account, is frequently discussed as a part of MRI-only RT workflow for
the future [1, 3, 4, 5].
Figure 2.7: Comparison of conventional and MR-only workflow in RT simulation.
Nevertheless, there are several concerns associated with MRI-only RT. The main
issue is that MRI intensities correlate with the magnetic relaxation and proton
density rather than electron density and radiation attenuation properties of tissue.
Consequently, the voxel intensity of MRI image does not reflect radiation attenuation
characteristics of the tissue as it is in the case of CT image. This results in contrast
ambiguity in the case of tissue types like air and bone which both appear dark on
the MRI despite having distinctive electron densities. The lack of correspondence
between the voxel intensity and the associated electron density presents a challenge
for performing dose calculations using MR images as a basis [43].
Further challenges are posed by geometrical distortions originating from magnet
inhomogeneities, gradient non-linearity and artefacts induced by the patient [46].
Spatial variance in the MRI signal of tissue (such as subcutaneous fat most notably)
convolutes its conversion into Hounsfield unit (HU). Normalisation of signal intensities
and inhomogeneity corrections may need to be applied on the MR images. The final
HU or electron density map is called synthetic or pseudo-CT (pCT) [43].
2.3.2 Pseudo-CT generation methods
Several methods of pCT image generation using one or more MRI contrasts have
been reported in literature. These methods can be classified into two basic groups.
The first group is represented by voxel- or data-based approaches, and so-called atlas-
based methods belong to the second category. Patch-based methods can be included
in this second category as well. Moreover, the use of hybrid or mixed approach of
pCT generation taking advantage of both atlas- and voxel-based approaches has been
reported as well.
14
Voxel-based methods In the voxel-based approach, individual voxel intensities
of the MRI scan are used for prediction of pCT voxel HU values, either by employing
a regression model to generate a continuous-valued image or by segmentation and
consecutive bulk HU value assignment [1, 47, 48]. However, the generation of
continuous-valued pCT is challenging due to the degeneracy of the fitted relationship
between image intensities in MRI and CT images [47]. Since the MR contrast is
utilised independently of the spatial location of the voxel, relatively low computational
demands constitute a potential advantage of voxel-based methods for the use in
clinical practice [43].
Besides the reliability and the prediction accuracy, the pCT recon time is a critical
factor for the successful implementation of MR-only workflow in the clinical practice.
However, the very short T2 relaxation time of cortical bone represents a di culty for
accurate voxel-based pCT prediction. Neither air nor bone provides any signal when
standard clinical MR imaging sequences are used. Consequently, a dedicated MR
sequence together with post-processing steps such as air-mask generation must be
utilised for obtaining a correct classification of bones and air cavities when employing
voxel-based methods for pCT generation [48, 49].
Atlas-based methods In the atlas-based approach, an atlas consisting of co-
registered CT and MR image pairs is employed in pCT generation. The target
MR image is firstly non-rigidly registered with all the MR images that form the
atlas. The number of registration steps depends on the extent of this atlas. A single
registration step is needed in the case when the atlas includes only one CT-MR
pair of template (average) patient [43]. Nonetheless, the use a so-called multi-atlas
approach is more common due to its higher pCT prediction accuracy. This approach
requires the execution of multiple target-atlas MRI registration steps, and therefore,
is less computationally attractive. Secondly, the displacement fields obtained from
the registration process are applied to all of the CT scans paired with MR images in
the atlas [48]. And finally, a single pCT image is obtained by fusion of these deformed
CT images. In this fusion process, pure intensity averaging, majority voting, or other
more sophisticated methods are employed in the determining of final voxel HU values
in pCT image [43].
Atlas-based methods provide the solution for separation of air and bone even
in the case when standard MRI sequences are employed. However, the atlas-based
approach su ers from uncertainty in the registration of the atlas [50] and poorly
able to cope with high variability in electron density and/or anatomy between
patients [47]. Especially the anatomy of an atypical shape such as surgical implants
or missing tissues poses a particular problem for atlas-based pCT generation [2].
Consequently, post-processing steps may play a crucial role in increasing the pCT
prediction accuracy of such atlas-based approaches [50].
Other methods Since both atlas- and voxel-based methods each have favourable
and unfavourable factors so-called hybrid methods aiming to utilise advantage of
both categories have been reported in literature as well [43]. Such hybrid method
could, for instance, be based on the estimation of two probability density functions
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for each voxel, one based on Bayesian statistics and the other based on deformable
registration. These two probabilities would be then merged into single probability
density function determining the final HU value assigned to the voxel [51].
A di erent hybrid approach could, for instance, be built on classical atlas-
based methods whereas voxel-based methods would be employed in the image post-
processing. These processing steps would aim to improve the prediction accuracy in
regions with individual anatomies [48]. The last category is formed by the hybrid atlas
methods combining several approaches within the atlas-based methods. This could
be a method integrating patch-based methods using pattern recognition together
with a classic deformable registration approach [1, 43].
2.3.3 MR imaging parameters
Generation of pCT poses some special requirements for the MR imaging parameters.
Multiple strategies for selection of MR imaging parameters have been reported in
literature. The preferred image contrast is highly influenced by the method of pCT
generation.
Atlas-based methods In atlas-based methods clinical MRI sequences are usually
employed. MR images obtained with standard clinical sequences [1] are preferred
simply because of their general availability, which is of crucial importance when
multiple CT-MR co-registered image pairs are needed to build an atlas. These
clinical sequences are T2 (long TR, long TE) and T1 (short TR, short TE) weighted
depending either on the transverse (T2) or longitudinal (T1) tissue relaxation. The
choice of TR and TE are then the main factors influencing the final image contrast.
The acquisition of MR images is the most commonly carried out using either of a
gradient echo (GE) or spin echo (SE) sequences [43].
Voxel-based methods Voxel-based methods for pCT generation usually require
the use of special MR sequences. These sequences typically produce images of multiple
contrasts mostly specialised on bone visualisation, which is a very challenging task in
the case of MR imaging. The acquisition of such MR images is usually accomplished
by the use either of Dixon or dual ultrashort echo time (dUTE) sequences [52]. Lately,
though zero TE MR imaging has shown even more promise than dUTE [53].
Dixon is a family of water-fat splitting sequences and relies on the chemical shift
between the resonance frequencies of water and fat. Dixon images can be weighted
in the direction of T2, T1 or fl as the separation of fat/water is not based on TE or
TR.
MRI sequences based on dUTE are specialised on visualisation of cortical bones
and have an ultra short T2 relaxation time [43]. The use of this sequence type,
therefore, allows separating bone from air voxels [52]. The initial signal is in dUTE
sequence collected immediately after the excitation, and the second signal is acquired
later with a longer echo-time. The initial image is T1 or fl weighted depending
on the flip-angle. The second image has a T2 or T1 weighted contrast depending
on the flip-angle and the echo-time [43]. However, utilisation of dUTE sequence
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introduces prediction errors into pCT images, particularly at tissue interfaces located
in the proximity of nasal cavities and ears. This has been associated with low SNR,
susceptibility e ects as well as partial volume e ects in dUTE images [54, 55].
2.4 Quality assurance in MR-only RT
2.4.1 Dose-volume histogram
The output provided by TPS usually encompasses an enormous amount of information
about the dose distribution. The interpretation and evaluation of such data would
be di cult without the availability of a method that would condense data from the
3D dose distribution in the form of simple 2D graph [26, 25].
Such a graph is called a dose-volume histogram (DVH) which is a plot of dose on
the x-axis versus the volume of the particular structure on the y-axis. There exists
two versions of this graph di ering in the way of how the absorbed dose is interpreted
[56]. The first version is a di erential DVH, which directly shows the absolute or
relative dose value assigned to a particular bin in the histogram [25]. The second
and more frequently used is the cumulative version of DVH. Here each histogram
point captures dose that has been accumulated from previous bins starting with the
bin containing the highest dose moving in the direction towards to the one with
zero dose. In other words, such a DVH displays the dose absorbed in a particular
volumetric fraction of the target volume or OAR [26, 25]. The example of cumulative
DVH is shown in figure 2.8.
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Figure 2.8: An example of cumulative DVH showing two PTVs and selected OARs in
the brain. The blue line indicates that all of the PTV 1 receives a dose of 1600 cGy,
whereas roughly 20% receives a dose higher than 2000 cGy.
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The shape and area of the DVH curve provide information whether the target
volume is adequately covered with a prescribed dose and whether the dose delivered
to OARs is within the acceptable limits [14]. In the ideal case, the DVH would show
the target at 100% and then drop immediately to zero indicating that the prescribed
dose conformally covers the entire target volume. The OARs lines would, on the
other hand, fall quickly to zero, implying that no notable dose has been accumulated
in their volumes [56].
The DVH is very powerful tool for dose comparisons, especially if one needs to
compare dose results of two or more RT plans [25]. Consequently, this method of
dose comparison is included in the vast majority of studies on MR-only radiotherapy
where the CT-based plans and dose distributions are usually compared with dose
distributions recalculated on pCT [14]. Nonetheless, there are some aspects that
should be taken into account in the planning and evaluation using DVH analysis.
The first aspect is that the dose sampling resolution that can have an impact on
the outcomes of the DVH analysis, particularly in regions with steep dose gradients.
Moreover, the main limitation of DVH lies in the lack of spatial information. The
DVHs simply show that e.g. cold and hot spots exist within the dose distribution,
but their position is not indicated, nor whether there are multiple small low- or high-
dose regions or a just a large one [26]. The use of other methods capturing the spatial
information is therefore employed in dose evaluations as complementary to DVH
analysis.
2.4.2 Gamma analysis
Gamma analysis was initially developed for comparison of measured and calculated
dose distributions as part of the TPS commissioning process [57]. This quality
assurance (QA) method takes into account both the dose and distance criteria. The
gamma analysis execution starts with computation of “(r˛t, r˛c) series, which is defined
as
“(r˛t, r˛c) =
ıˆıÙ |r˛t, r˛c|2
DTA2
+ |D(r˛c)≠D(r˛t))|
2
D2max
, (2.1)
where r˛t is the reference and r˛c is the comparison point in the dose distributions to
be compared. The distance between evaluated points and dose di erence are termed
as |r˛t, r˛c| and |D(r˛c)≠D(r˛t))|, respectively. The resulting gamma index is defined
as “(r˛c) = min “(r˛t, r˛c), and serves as a quality measurement. The gamma index
indicates the level of failure in the areas that do not meet the acceptance criteria and
determines quality in regions that pass the analysis. Since this index is determined
for each voxel in dose grid separately, it can be easily presented as a so-called gamma
distribution that is overlaid on the CT or pCT image [57, 58].
The essential input parameter for gamma analysis is a pass–fail criterion which is
determined by the user for both the distance-to-agreement (DTA) and maximum
dose di erence (Dmax), e.g. 2% and 2mm. These criteria can be identified as scaling
factors in equation (2.1), and have equivalent significance in the evaluation of the
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gamma analysis. Dose distribution points failing one or both criteria are pinpointed
on a composite distribution [58]. The normalisation for dose di erence can be either
local ( D between voxels) or global where  D is defined as e.g. percentage of
maximum dose point of the reference dose distribution [59].
The other parameters that need to be determined by a user are the passing rate
and dose cuto . The passing rate is threshold used for decision of whether the entire
dose distribution passes or fails the gamma analysis. This threshold is defined as
a percentile of dose grid points needed for passing the test. The dose cuto  is an
optional parameter reducing region within which is the gamma analysis calculated.
This region of dose grid is determined by isodose in percents [57]. The point of
adding the cuto  parameter is that gamma index gives a relative di erence in dose.
For instance, if the absolute dose is small, a large relative di erence then does not
have any clinical impact. The fundamental principle of the gamma analysis is shown
in figure 2.9.
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Figure 2.9: The simplified concept of gamma analysis for 2D dose distribution. x, y,D
are spatial and dose dimensions. Dmax is maximum acceptable dose di erence. DTA
criterion is determined by the radius of the red horizontal circle (sphere for 3D
distribution).  r,  D are spatial and dose di erence of the blue point. The blue
point, in this case, fails both criteria (Dmax, DTA) of the analysis [58].
2.4.3 Spatial accuracy requirements
The CT-MR fusion introduces a registration error into the standard RT simulation
workflow. This mean systematic error has been reported to be approximately
1.8± 2.2mm (average displacement and one standard deviation) in the case of brain
RT [60, 61]. This value is comparable to other body sites such as the prostate [46].
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The MR-only workflow could, therefore, reduce these registration errors between MR
and CT scans [10, 47]. However, MR imaging is known to be susceptible to distortions
that alter both the relative intensity (spatial variation) and spatial representation of
displayed anatomical structures. These distortions originate either from the MRI
system itself or may also be induced by the patient.
The source of the object related distortions are variations in chemical shift and
susceptibility of the sample, while the system-induced distortions are caused by
gradient nonlinearities and inhomogeneities in the main magnetic field B0. Conse-
quently, the MR images intended for MR-only RT simulation have to be corrected to
a level that would be acceptable for radiation therapy planning. The overall spatial
error should be lower than 2mm [10] in order to not exceed the registration error of
standard workflow when both CT and MR images are used in RT planning process.
Regarding geometrical and image intensity accuracy, a distance to the agreement of
 r = 2mm and a deviation of  H = 100HU have been claimed to be acceptance
levels for pCT image [48].
Even with the use of the stereotactic frame, an average CT-MRI fusion error of
around 2mm was stated for SRT [60]. Cranial SRT and SRS are both increasingly
carried out by use of frameless fixation devices [62] as the similar error of 2mm
was reported to be feasible for frameless workflow. However, there is a 5% risk of
outliers of up to 5mm [63]. Since small margins are usually used in modern IMRT
and VMAT brain plans (< 5mm), such registration inaccuracies could potentially
cause a critical overdose in OARs or target miss [64]. MR-only RT could possibly
reduce these registration errors.
2.4.4 Dose accuracy requirements
Establishing dose accuracy requirements is a key step in the comparison of the
MR-only brain RT workflow to the standard workflow. MR only RT workflow was
reported to be acceptable when the PTV mean dose deviates less than 2% from the
original CT-based calculation in 95% of patients [5]. Nevertheless, limits for clinically
acceptable deviations in other DVH statistics have not been yet established for the
brain. Consequently, a proposal has been made of initiating a population-based
study comparing CT-based dose calculations with those carried out on the pCT [5].
Regarding the gamma analysis, the 1%/1mm, 2%/2mm and 3%/3mm criteria
were previously used for comparisons of dose distributions calculated on pCT and CT
images of head [65, 59]. However, the specific clinically acceptable gamma passing
rates for brain have not been reported in any of the available literature sources.
The overall impression from the literature is that a gamma criteria of 1%/1mm,
2%/2mm or their combination could be used as an indication of clinically acceptable
dose comparison.
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3 Materials and Methods
3.1 Clinical data
Radiotherapy planning datasets were obtained from Turku University Hospital in
Finland (TYKS), from where two patient cohorts were selected for analyses presented
in this thesis. This data included patients with various diagnoses and treatment
strategies. The first cohort of 10 cases was aimed for the bulk HU estimation and
subsequent PTV position dose analysis. The second sample of 10 cases (see table 3.2),
partially overlapping with the first cohort, was used for a technical approximation of
clinical plans.
3.1.1 Data characteristics
The majority of treatment strategies encompassed the combination of surgery fol-
lowed by radiotherapy. Nonetheless, few patient cases with the standalone use of
the radiotherapy were observed as well. RT-only treatments were typically either
palliative treatments, treatments of tumours located in the proximity of brainstem,
or treatments of the small benign lesions where the surgery would not be reasonable
or would pose a very high risk of permanent disability.
(a) (b) (c)
Figure 3.1: Example of the patient image set. CT (a), T1 weighted (b) and T2
weighted MR image (c).
CT and MRI datasets including FLAIR, T1 and T2 weighted images were available
for the majority of the patient cases. The information about the spatial registration
between these CT and MR images was attached as well. The radiotherapy planning
data comprised RT structures, RT dose, and RT plan exported from Eclipse (Varian
Medical Systems, USA) treatment planning system (TPS) in the form of DICOM
files. The RT structure file contained delineations of both, the anatomy of OARs,
and target volumes (TVs) in the form of 2D contour in axial slices. The RT dose file
included a 3D dose distribution, which was the outcome of RT plan optimisation
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algorithm implemented in TPS. The RT plan DICOM file contained parameters,
such as beam type and directions, positions of MLC leaves at all the control points,
dose prescriptions, and other physical parameters that are usually estimated by
medical physicist upon the RT planning process.
3.1.2 Image parameters
The image sets showed a high variation in parameters such as voxel size, the field of
view (FOV) in the case of CT, and contrast in the case of MR images. Even though
a resolution was roughly consistent in axial slices among all CT images (512◊ 512
voxels), the problem was a variation in slice thickness (1≠ 2.5mm) having an impact
on the overall spatial resolution. The low spatial resolution increases the incidence of
partial volume e ects that play a crucial role in a specificity of tissue segmentation
[66, 67] and consequently in bulk HU estimations as well. In the case of MRI, the
small voxel size causes a decrease of SNR and increase in image acquisition time.
The variation in contrast and voxel intensity was in our case a particular issue in the
MR image segmentation, which was needed for the brain tissue stratification.
3.1.3 Pathologies and artefacts
(a) (b) (c)
(d) (e) (f)
Figure 3.2: Artefacts and pathologies observed in multiple head CT images. Multiple
drilling sites (a), metallic artefacts (b), metal probe (c), extensive calcifications (d),
occipital craniotomy (e), and skull clips (f).
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The majority of obtained images showed pathologies including skull drills and resec-
tions. Moreover, calcifications and artefacts from dental implants were abundant as
well, as patients with the brain cancer usually belong to the upper age group (40-65
year in the case of gliomas) [68]. Metallic implants are responsible for artefacts or
distortions in both CT and MR images. The combination of mechanisms such as
scattering, beam hardening, Poisson noise and edge e ects are the cause of these
artefacts in the CT image [69]. Figure 3.2 shows six selected patients with apparent
pathologies that were visible in their CT images.
3.1.4 Data preprocessing
Several preprocessing steps were undertaken to mitigate the impact of image param-
eters variation, artefacts and individual pathologies on estimates of bulk tissue HU
that were issued for the fCT generation.
Firstly, all the CT and T1 weighted MR images were inspected visually in order
to select 10 suitable patients cases for the estimation of bulk tissue HU values. These
cases should include images free from metallic artefacts, craniotomy and low brain
tissue contrast in T1 images. Selected CT images were further cropped using an
annotation ROI tool in the 3D Slicer (BWH, USA) [70] in order to unify the FOV
among all the selected cases. The C2 vertebrae in the sagittal plane were used as
the anatomical landmark for the cropping.
Secondly, the T1 MR images were rigidly registered to the CT images. The
transformation matrices used for the rigid registration were in the majority of cases
available as part of raw TYKS data. Cases without the availability of the spatial
registration file were rigidly registered using the constraint of six degrees of freedom
(DOF) when performing the image registration in the 3D Slicer. MR images were
resampled into the voxel resolution grid of corresponding CT images. This step was
needed for the unification of the spatial resolution between CT and MR images for
the further processing and segmentation using the Python programming language.
Consequently, the low spatial resolution of the CT resulted in a quality decrease of
the resampled MR image.
(a) (b) (c)
Figure 3.3: Cropped CT image where C2 served as the anatomical landmark. Axial
(a), sagittal (b) and coronal view (c).
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Finally, the other set of image pairs (CT and T1), with further reduced VOI,
was generated for the purpose of bulk tissue HU calculation. The most distal part
of the skull was used as the anatomical landmark for image cropping in the axial
direction. This landmark was either the base of the occipital bone or the mastoid
process depending on the patient positioning. The reason for this step was to reduce
the impact of voxels not likely to be within the beam path on the bulk tissue HU
estimations. The second reason was to reduce the impact of large metallic artefacts
from dental implants shown in figure 3.2b.
3.2 Generation of head volume mask
Generation of a binary mask, covering entire head volume including inner air cavities,
was an important step for several reasons. Firstly, the binary mask was used for
classification and distinguishing of the inner air within the head volume from the
background air. The mask was also used as the template for the further segmentation
into single tissue classes. Secondly, the modification of this mask, where inner voxels
were replaced by corresponding HU of water and the air HU was assigned to the
background served as the reference water-filled fCT (fCTw) in dose comparisons.
And finally, the binary head volume determined the VOI from which were calculated
all metrics that were used for the evaluation of the segmentation accuracy.
3.2.1 Morphological operations and connected-component labelling
The morphological binary image processing was repeatedly used in several stages of
medical image processing employed in this thesis. Binary morphological operations
were used for e.g. the thermoplastic mask removal, generation of the head binary
mask and calcification detection as well as for automated skull-stripping which was
necessary for the brain tissue segmentation. Especially the opening operation, which
is simply the erosion followed by dilatation, has frequently been used. The purpose
of this section is, therefore, to preclude the repetitiveness in method description in
following chapters. It should be noted, that all the presented methods and operations
are well applicable in the 3D image processing, however, for simplicity and better
understanding are the basic principles demonstrated on simple 2D binary images.
The elementary principle behind the binary morphology is to probe the image
with a kernel that has a pre-defined shape. This binary kernel is called the structuring
element represented as B in equations (3.2) - (3.4). This structuring element B is
primarily drawing conclusions on how this shape misses or fits the shapes in the
binary image [71, 72].
Morphological dilatation and erosion In the morphological image processing
the binary image is represented as a collection of non-zero points of the plane P . The
transformation Xz = {y | y = x+ z, x œ X} defines the translation of the set X µ P
by the vector z œ P . The equation (3.1) shows Minkowski addition X,B µ P which
is also known as dilatation [72]. The process of dilatation is shown by figure 3.4.
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Figure 3.4: Dilatation of 2D binary image with 8-neighbourhood structuring B (left)
and eroded image (right) (source: [73]).
X üB = {x+ b | x œ X, b œ B} (3.1)
figure 3.5 displays the process of morphological erosion, also called the Minkowski
subtraction, which is described by equation (3.2) [72].
Figure 3.5: Erosion of 2D binary image with 4-neighbourhood structuring B (left)
and dilated image (right) (source: [74]).
X °B = {z œ P | Bz ™ X} (3.2)
Morphological opening and closing Besides the dilatation and the erosion,
there are two secondary commonly used morphological operations that are termed
as opening and closing. Especially, the opening is handy for an elimination of small
image components [71]. The opening is described by equation (3.3) as the erosion
followed by dilatation.
X ¶B = (X °B)üB (3.3)
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The closing of the binary image can be written as the erosion that follows after
the dilatation in the way as is shown in equation (3.4).
X •B = (X üB)°B (3.4)
Connected-component labeling The connected-component labelling can be
used for the partitioning of the binary image into the disjoint sets (components).
This method was used e.g. for the automatic skull stripping, where the brain
volume was detected as the largest component of the eroded soft tissue label. The
connected filter works in the way of merging the connected components and assigning
them new label numbers, colours or di erent grey levels [72]. The process of the
connected-component analysis is displayed by figure 3.6.
Figure 3.6: Process of connected-component labeling in 2D binary image (source:
[75]).
3.2.2 Removal of thermoplastic mask from CT
CT images used for RT planning must be acquired with the patient in the treatment
position. Consequently, all CT images contained the fixation and positioning devices
such as thermoplastic masks or positioning boxes. Thermoplastic masks are not
visible in MRI, and therefore, they need to be removed from the CT image to allow
a one-to-one comparison against prospective pCT. Moreover, the presence of such
background objects would pose a problem for the generation of the binary head mask.
The thermoplastic mask removal was accomplished via an appropriate combination
of fundamental image processing operations. In a first step, the 3D median filtering
was applied in the CT image in order to remove noise and decrease the intensity
within small components, which belong to the thermoplastic mask, by taking the
neighbourhood background air voxels into account. The initial binary head mask
was generated by applying a relatively high threshold of ≠250HU, separating the
background air voxels from those with higher intensity. A relatively high threshold
helped with a further elimination of small elements that were located outside of the
head volume.
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The conversion into binary image enabled the use of morphological image pro-
cessing such as the erosion which was applied for further elimination of small islands
having a high HU and for generation of disjoint sets that could be easily detected and
removed by the connected component labelling. The final step was the application
of dilatation with slightly larger structuring element to substitute losses caused by
both, the use of high HU threshold (≠250HU), and by the morphological erosion.
The final binary mask could be then easily used for the removal of the thermoplastic
mask from the CT image as it shown in figure 3.7.
(a) (b) (c)
Figure 3.7: CT volume after the thermo-plastic mask has been removed. Axial (a),
sagittal (b) and coronal view (c).
3.2.3 Filling of air cavities
The filling of the holes in 3D images comes with special conditions that must be
taken into account. This in particular applies to holes that are not fully closed in the
three-dimensional space. Good examples of such cases are nasal cavities or external
auditory canals. Although these cavities are represented as holes in two-dimensional
coronal and sagittal plane, these holes are open in the 3D space or the axial plane.
Consequently, the 3D flood filling algorithm fails in the filling of such holes.
Active-contour model The aforementioned problem was solved by the use of an
active contour model which is also known as a snake. The snake fulfilled a role of
artificial plasters for closing all the opened holes in the axial plane such as mouth
cavity, upper airways and external auditory canals.
The goal of active contour model is, in general, to integrate the measurements of
local image changes such as edges and lines into the form of contours delineating
the entire image objects. It is an energy minimising problem searching for the curve
travelling across the image regions with small values of the energy function. The
simple snake can be parametrically described as v(s) = (x(s), y(s)) and its energy
can be then written as it is shown in equation (3.5), where Eint is the internal energy
of the contour by cause of bending, Eimage give rise to the image forces and Econ
represents the external constraint forces. The constraint energy is the optional term
that can be used for interactively guiding the snake away or towards to specific
features [76].
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Eúsnake =
⁄ 1
0
Esnake(v(s))ds =
⁄ 1
0
Eint(v(s)) + Eimg(v(s)) + Econ(v(s))ds (3.5)
The internal energy of the snake, which is expressed by equation (3.6) consists of a
one first and one second order term. The first order term causes snake behave as
a membrane and its weight –(s) controls the relative importance of this behaviour.
The second order term, which is controlled by a weight —(s), makes the spine act
like a thin plate [76]. The role of these weights that are determined by user is to
control the amount of stretch and curvature in the snake, and therefore, to rule the
level of constraints on the shape of the contour.
Eint = (–(s) | vs(s) |2 +—(s) | vss(s) |2)/2 (3.6)
Energy of the image shown by equation (3.7) is a weighted combination of three energy
terms (Eline, Eedge, Eterm) where each of them makes the snake attracted to di erent
image features such as lines, edges and termination. Weights (wline, wedge, wterm)
determine the impact of single energy terms on the final energy of the image. In the
case of Eline the sign of the weight wline makes snake to be attracted either to dark
or light lines. The termination energy Eterm takes advantage of principle that the
curvature of level lines in a smoothed image can be used in detection of features like
terminations and corners in the image [76].
Eimg = wlineEline + wedgeEedge + wtermEterm (3.7)
3.2.4 Generation of filled head mask
The only input into the filled head mask generation process was the binary volume
without the components of the thermoplastic mask. In a first step, two active contour
models were applied in axial slices of the input image by use of the Skimage Python
library. These axial slices were slightly smoothed by the utilisation of the Gaussian
kernel in order to emphasise gradients around edges.
The reason for the application of two snakes was a requirement on contour to
behave like balloon or plaster that would close the nasal and mouth cavities. However,
this e ect would be not desirable for proper delineation of ear lobes. Consequently,
the first snake was used for generation of the anterior mask with weights optimised in
a way that made the contour finely delineate the shape of the nose while the balloon
e ect did not let it proceed to move further inside to cavities. This behaviour is
shown in figure 3.8a, where the blue line represents the actual snake, and the red
dashed line is the initial contour obtained from dilated version of the binary head
mask. The second snake, which was used for generation of the posterior mask, is
shown in the figure 3.8b. In this case, all weights were selected to reduce the amount
of stretch and curvature in the snake to get rid of inheritance of earlobes from the
initial contour. This contour was, in this case, obtained using the image closing
operation applied on the binary head mask.
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(a) (b) (c)
Figure 3.8: Generation of anterior and posterior masks for filling of open air cavities
in binary mask obtained from the CT image by use of active contour model. Outer
contour for generation of the anterior mask (a). Inner contour for generation of the
posterior mask (b). Filling of open air cavities using the generated masks (c)
The iteration number was reduced to 50 in order to shorten the computation
time needed for the generation of final contours. Since contours were optimised to
delineate only structures that occur in specific locations, the application of snakes
was, therefore, reduced into the defined range of axial slices. Moreover, this step
further reduced the computation time and more importantly, it decreased the risk of
faulty delineations of structures located in more superior and inferior regions.
The readily detectable tip of the nose with a margin of two slices in superior
direction was used as the anatomical landmark for termination of anterior mask
generation process. In the case of the posterior mask was used the relative range of
axial slices that covered the entire ears in all the tested patient cases.
Subfigure 3.8c show the combination of generated masks covering all the open
cavities. Since these masks did not cover all closed holes located within the head
volume, the 2D flood fill algorithm was applied separately to all the axial slices in
order to fill remaining cavities. This step followed by slight dilatation resulted in the
final binary head mask.
3.3 Tissue stratification for MR-only RT
The CT tissue stratification was together with the bulk tissue HU estimation necessary
steps in the generation of flattened CT (fCT) images. The segmentation was
performed using two image modalities, CT and T1 weighted MR images. Hence, two
di erent segmentation methods were selected based on properties of the source image
and desired segmentation outputs. The K-means clustering was found suitable for
the label generation in the case of tissues with high signal-to-noise ratio (SNR) in CT
image. Brain tissue consisting of the cerebrospinal fluid (CSF), white matter (WM)
and grey matter (GM) that have all low SNR in the CT were segmented using the
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T1 MRI as the source image. The Markov Random Field with Iterated Conditional
Modes optimisation (MRF-ICM) algorithm, taking the information from the voxel
neighbourhood into account, was employed in this process.
3.3.1 CT image segmentation
All tissue classes with high SNR in CT images, and therefore, with significantly
di erent HU values were segmented by use of the K-means clustering. These tissues
were fat, water-rich tissue, bone marrow and compact bone. The label for air cavities
was acquired from the intensity thresholding with a threshold of ≠500HU. This
threshold was carefully selected based on reports in literature [77] and partly from
the testing upon the segmentation process. The main goal was to mitigate the impact
of strong partial volume e ects at the interface between the air and tissue classes on
the estimation of bulk tissue HU values. The K-means CT segmentation, therefore,
covered only voxels located within the head mask excluding all voxels belonging to
air class.
K-means segmentation K-means clustering belongs to a group of partitioning
clustering methods. The main goal of K-means clustering is to divide input data points
X = {x1, ..., xN} into K clusters by minimising the following objective function:
JKM =
Nÿ
n=1
Kÿ
k=1
Îxn ≠ ckÎ2 , (3.8)
where Îxn ≠ ckÎ2 is a chosen distance measure between data point xn and cluster
centre ck. The variable Nk denotes the number of data points in corresponding
cluster Ck [78]. An overview of K-means clustering is shown in figure 3.9.
Figure 3.9: Diagram showing the principle of K-means clustering algorithm
Each voxel is in the K-means based image segmentation characterised by a
feature vector. This vector consists of one or more components, where each of these
components represents one feature employed in the clustering process. These feature
vectors are formed into the input matrix X with a dimension of M ◊N , where M
denotes the number of features.
In the present study, feature vectors including two components were defined for
the purpose of the CT segmentation. The first component was the original voxel
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intensity in HU units. The second feature was median intensity obtained from the 3D
kernel surrounding the voxel for taking the information from the voxel neighbourhood
into account. The other reason for using this feature configuration was the existence
of literature records showing that 2D K-means clustering using two features provided
better bone segmentation outcomes than in comparison with other clustering methods
such as Fuzzy C-Means and 1D K-means clustering with the one image intensity
feature [79]. The kernel size used for the median image filtering varied based on slice
thickness of the CT image. This kernel size was calculated based on the resolution
of the CT image input. The kernel approximating the ball or ellipsoidal shape with
a radius of 2 voxels in all three image planes was used in the case of CT images with
the slice thickness of 1mm. In the case of slice thickness of e.g. 2mm, kernel radius
of 1 voxel in the anterior-inferior direction was employed. The generation of the
median filtered image was accomplished by use of the SimpleITK library in Python.
An example of CT images that served as features is shown by figure 3.10.
(a) (b)
Figure 3.10: CT images used as features for two-dimensional K-means segmentation.
The left image is the original CT (a) with cleaned background, and the right image
is the median-filtered CT (b) using the kernel radius of 2 voxels.
The Scikit-learn Python clustering library was employed in the execution of
the 2D K-means segmentation. The K-means++ method was used for the smart
selection of the initial cluster centres. This method tries to initialise centroids in a
way that they are far apart from each other using probability measures [80]. The
final tissue class label numbering was determined based on increasing order of mean
HU values within the clusters. The connected component labelling was employed in
the separation of calcifications and foreign objects from the bone labels.
Number of clusters In total, six clusters were used for the clustering where water-
rich tissue and fat were each represented by one cluster and spongy and compact bone
classes were each covered by two clusters. In this thesis, the terms of spongy and
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compact bone refer rather to bone compartments having a low and high density in CT
than to the anatomical structure of bone tissue. The presented cluster configuration
was selected based on intensity histogram of head CT image, where bones expressed
high variance of HU values without visible distributions in comparison with water-rich
tissue and fat classes where distribution peaks were clearly detectable. Moreover,
the silhouette coe cient was calculated in order to verify that data points lie well in
their clusters, where the silhouette coe cient is defined as
s¯ = 1
N
Nÿ
i=1
b(i)≠ a(i))
max {a(i), b(i))} , (3.9)
where variables a(i) and b(i) denote the intra-cluster distance and the mean nearest-
cluster distance for each data point [81].
3.3.2 MR image segmentation
The precise soft tissue contrast in MRI images allows relatively easy, reliable and
fast segmentation of soft tissue classes such as fat, CSF, the white, and grey matter,
that might have some e ects on the dose performance of the prospective pCT.
However, noise and low, spatially non-consistent MR signal intensity within tissue
classes are leading causes of the decrease of K-means classification accuracy. Thus,
there was raised a need for more advanced segmentation algorithm taking the voxel
neighbourhood information into account.
T1 MRI pre-processing T1 MRI images were selected as an input for the brain
tissue stratification. This process required the execution of a skull stripping on the
MR image. This process was accomplished by applying the image opening together
with connected component labelling within the binary tissue label. This label was
taken from the 2D K-means segmentation of the coregistered CT image. The result
of skull stripping is shown in figure 3.11.
(a) (b) (c)
Figure 3.11: The process of skull stripping by applying the morphological opening
and connected component labelling on binary tissue label taken from the CT image
segmentation (a). The generated brain label overlaid on the T1 MRI (b) and 3D
visualisation of the brain mask (c).
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The potential signal inhomogeneity in T1 MR images was corrected by use N4ITK
Bias Field Correction module implemented in 3D Slicer that performs image bias
correction with the N4 algorithm [82]. The contrast inconsistencies among T1 images,
introduced mostly by the use of contrast agents, were further resolved by thresholding
out the intensity outliers. This step was followed by intensity normalisation applied
within the brain tissue label.
MRF-ICM algorithm The use of Markov random field covers issues that are
of particular importance in the MR image segmentation. Such issues are e.g. the
neighbourhood correlations and spatial inhomogeneities in MR signal [83]. The base
of ICM algorithm lies in minimising the following energy function:
fij(w) =
1
2(
xij ≠ µw
”w
)2 ≠ —uij(w) + ln”w, (3.10)
where the potential — is a weighting factor. This factor estimates how much is the
final segmentation influenced by neighbourhood uij(w) of the voxel xij. The number
of neighbourhood voxels classified into same tissue class w is acquired from the
Gaussian mixture model (GMM) simulated by convolution between tissue labels and
3D kernel. This kernel covers the selected voxel connected neighbourhood.
The energy value is computed point-wise, and new labels are generated to classify
voxels into the class corresponding to the smaller energy value. Means µ, standard
deviations ” and neighbours uij(w) are updated at each iteration based on new
classification obtained from minimising the energy function. The classification
process is repeated. The initial image segmentation is usually generated by use of the
K-means clustering, and the MRF-ICM process ends when no single voxel changes
are detected or when the predefined number of iterations is reached. The process of
MRF-ICM segmentation is depicted in the figure 3.12.
Figure 3.12: Diagram showing the principle of MRF-ICM segmentation algorithm.
In this study, the initial neighbourhood information was generated from 3D
convolution between tissue labels extracted from the K-means segmentation within
the brain mask and 3D kernel covering the 18 voxels connected neighbourhood. The
ICM optimisation was terminated when single voxel did not change a tissue class
between individual iterations or when five iterations have been completed. This limit
for iteration count was used in order to further shorten the computation time and
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to prevent the algorithm from exaggerative smoothing of brain tissue labels caused
principally by the low contrast in some of the T1 images. The MRF-ICM algorithm
used in this study was implemented through coding in Python.
3.3.3 Bulk tissue HU estimation
A determination of bulk HU values is the input needed for the pseudo-CT (pCT)
generation using one of the voxel-based methods. The estimation of bulk HU values
was, therefore, the essential step in the production of flattened CT (fCT) images.
Bulk HU values were estimated as averages from corresponding tissue binary
labels within CT images. Mean HU values were initially calculated for each of 10
selected CT images separately. The final bulk CT number was determined as the
average of these estimates. This strategy further guaranteed the equal contribution
of each of selected CT images into the final results despite variation in the spatial
resolution. Since the brain tissue labels were generated from the MR image, the
registration error might have been responsible for uncertainties in the label positioning
when labels were overlaid on the CT image. This positioning error would certainly
cause discrepancies in bulk tissue HU estimation.
Furthermore, the fundamental property of CT image such low SNR in soft tissue
regions and high partial volume e ects might influence the bulk HU estimation as
well. The impact of all these undesirable e ects was, therefore, reduced by application
of the morphological erosion on tissue labels. In the case of CSF was the erosion
complemented with use of the connected component labelling. Hence, the average
CT number for CSF was estimated only from eroded ventricles. Modified brain tissue
labels are shown in figure 3.13. The HU value for air was calculated as the average of
all the image voxels (including background) with the intensity lower than ≠500HU.
(a) (b) (c)
(d) (e) (f)
Figure 3.13: Original and eroded brain tissue labels issued for the bulk HU estimation.
CSF label (a), WM label (b), GM label (c) and corresponding eroded labels (d-f).
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3.3.4 Flattened CT images
The final head tissue stratification was generated through the fusion of the MRI-based
MRF-ICM brain tissue segmentation with the 2D K-Means segmentation of the CT
image. Such 3D array containing all the labels then served as the template for the
generation of all versions of flattened CT (fCT). In total seven fCT configurations
were generated by filling of the tissue labels with corresponding bulk HU values.
The fCT naming convention was for simplicity determined as fCTx. The number
x represents the count of tissue classes encompassed in the corresponding fCT
configuration.
The simplest fCT2 version included only the bone and average tissue HU values
assigned to the corresponding tissue labels. The bulk HU calculated from the soft
tissue label was, therefore, in the case of fCT2 assigned to the air cavities as well.
The most detailed configuration named fCT8 then encompassed eight bulk HU values
for the inner air, fat, soft (water-rich) tissue, spongy bone, compact bone, CSF,
WM and GM. The calcification label was filled with soft tissue HU value of the
corresponding fCT version. The fCTw with HU value of water (0) assigned to entire
head volume was generated as a reference image for dose comparisons. The following
seven fCT configurations were generated: fCTw, fCT2, fCT3, fCT4, fCT5, fCT7 and
fCT8.
The final step in fCT generation was the conversion of the 3D image arrays into
the DICOM format. This action required the generation of artificial DICOM tags
that are part of metadata attached to the medical image. This metadata is needed
for making the generated fCT images readable by TPS or other clinical applications.
Table 3.1 shows summary of generated fCT images.
Table 3.1: An overview of generated fCT images and the tissues included in each
version
fCTw fCT2 fCT3 fCT4 fCT5 fCT7 fCT8
Water - - - - - -
Air cavities - -
Fat - - -
Tissue -
Bone - - -
Spongy bone - - - - -
Compact bone - - - - -
CSF - - - - -
White matter - - - - -
Grey matter - - - - -
35
3.4 Generation and processing of RT plans
All the RT plans included in this work were created in Pinnacle 16 (Philips, Nether-
lands) treatment planning system (TPS). Two groups of RT plans were generated.
The first group comprises of a large number of simplified plans used for PTV position
dose analysis. The second group encompassed so-called technical approximations of
clinical plans generated in Pinnacle TPS based on real clinical data. These plans
served as verification for whether the outcomes of the PTV position analysis are
valid also for RT plans that are similar to those employed in clinical practice.
3.4.1 PTV position analysis
Brain tumours vary greatly in position, size, and shape. Especially the position may
be of particular importance regarding dosimetric properties. The hypothesis was
such that medially located PTV surrounded by water-rich tissue may have di erent
requirements on the accuracy of fCT tissue stratification in comparison with PTV
located more laterally in the proximity or directly covering the skull.
The use of multiple RT plans with PTV positions distributed in a manner that the
entire brain volume is covered appears to be a good way of investigating dosimetric
properties of all of the generated fCT versions. The PTV dose position analysis
presented in this thesis was carried out on a cohort of 10 patients. In total six PTV
positions and corresponding RT plans were generated for each of the patients. These
CT-based plans were then simulated on all seven fCT configurations. This analysis,
therefore, encompassed 480 RT plans.
PTV parameters and positions The first stage of the PTV position dose
analysis was to determine the shape and size of the PTV, whereupon the spherical
PTV with a diameter of 4 cm was selected. The primary reason for this selection
was a good comparability and simple reproducibility of PTV contours. Moreover, a
similar approach using spherical PTV with diameters ranging between 2 and 7 cm
was reported in literature [1, 61, 64, 84, 85].
These spherical PTV contours were placed in six positions covering the entire
cerebrum and cerebellum. The first PTV (annotated as SC) was placed superiorly
in the brain centre between the two hemispheres. PTVs were further positioned
anteriorly (A) within the frontal lobe, and posteriorly (P) partly including both
parietal and occipital lobes. Next two PTVs were placed contralaterally towards the
left (L) and right (R) roughly covering the temporal lobes. Since the head symmetry
might be a potential cause of duplicates in results, the PTV R was moved more
laterally to partially cover the skull. The last sixth PTV was positioned in the
cerebellum (CR). Figure 3.14 shows all the PTV positions and the selected naming
convention.
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(a) (b)
Figure 3.14: Distribution of six spherical PTV with diameter of 4 cm throughout the
brain. Displayed are the superior-central (SC) - red , anterior (A) - blue, posterior
(P) - green, left (L) - cyan, right (R) - magenta and cerebellar (CR) - orange PTVs.
RT planning process The RT planning process started with the selection of
the primary CT image, which was used for dose calculations. For the purpose of
the PTV position analysis, a modified version of the CT images was used. Here,
calcifications were replaced by the average HU value of soft tissue, and all voxels
that were exceeding HU value of 2000 were filled with mean compact bone value (see
table 4.1). The thermoplastic mask (TM) was removed as well. This modification
was carried out to ensure that only the tissue detectable by MR imaging and/or pCT
generation algorithm had an impact on dose comparisons. The CT-density table was
obtained from TYKS, and electron densities listed in this table were converted into
the mass density required by the Pinnacle.
The LINAC parameters that correspond to the Novalis Tx (Varian Medical
Systems, USA) machine equipped with the HD-MLC were selected for the RT
planning process as the use of this LINAC was detected in the majority of TYKS RT
plans. This LINAC is designated for delivery of highly focused SRT/SRS treatments.
The HD-MLC is folded from 60 leaf-pairs where leaves located in the central part of
MLC have a width of 2.5mm while those located at the edges have a width of 5mm.
Two VMAT arcs with isocenter located in the centre of the spherical PTV were
used. The first coplanar arc had a full arc of 360¶ and was parallel to the axial plane.
The second 180¶ arc was perpendicular to the axial plane, and the MLC field was, in
this case, rotated over the 45¶ in order to further improve the MLC shaping around
the PTV. The primary aim of employing the second arc was to enable very steep
dose gradients surrounding the PTV.
A fine control point (gantry) spacing of 2¶ was selected in order to reduce small
but conspicuous interpolation errors that can occur when a gantry spacing of e.g.
4¶ is applied [32]. The spatial resolution of the 3D dose grid, which is employed in
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dose calculations was selected to be 2mm in all three coordinates. A similar dose
grid resolution has been previously reported in literature for brain and head&neck
RT planning [32, 86]. Moreover, this resolution was observed in the majority of the
IMRT plans and some of the VMAT plans that were obtained from TYKS.
Two additional RT contours were automatically generated for each of the PTV
positions in order to better guide the dose optimiser to the desired dose gradients.
These structures were generated by use of scripting in Pinnacle. The first structure
covering the entire head volume excluding the PTV + 0.5 cm margin served as an
avoidance structure (see 3.15a). The second contour was a RING or sphere covering
2 cm margin directly around the PTV (normal tissue), which was used as simplified
OAR in subsequent DVH analysis (see 3.15b). Examples of these RT structures and
arrangement of dynamic VMAT arcs are shown in figure 3.15.
(a) (b) (c)
Figure 3.15: Avoidance structure - green and PTV (red) (a). RING/sphere (blue)
that covers healthy tissue around PTV (red) (b). An arrangement of dynamic arcs
in the simplified RT plan (c). Full arc (levender) and perpendicular half arc (yellow).
Optimisation objectives All generated plans were optimised using the auto-
planning feature in Pinnacle [87]. The direct machine parameter optimisation
(DMPO) algorithm [88] was employed in this auto-planning process. The PTV
position analysis included a generation of six reference CT-based VMAT RT plans
for each of the 10 patients (total 60 plans). Optimisation objectives, therefore,
had to be selected carefully in order to obtain well-optimised plans from the single
auto-planning trial. This condition was fulfilled through the selection of appropriate
LINAC, arc arrangement and especially by estimation of objectives such as dose
prescriptions and constraints.
The prescribed dose was selected to be 60Gy divided into 30 fractions (2Gy per
fraction) delivered to the PTV. This prescription roughly corresponds to the one,
which is clinically used in high-grade glioma RT treatment [41, 89]. The maximum
dose constraint that was assigned to the avoidance structure was determined as
10% of the prescribed dose. Even though this objective was not fully achievable,
this very strict dose constraint forced the optimiser to produce an RT plan with
PTV conformally covered by the 95% dose isosurface while having very steep dose
gradients adjoining the PTV.
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3.4.2 Technical approximation of clinical RT plans
Since the original RT plans from TYKS were generated using Varian Eclipse TPS,
and as Pinnacle does not allow the import of RT plans stored in DICOM format, the
RT plans could not be transferred into the Pinnacle TPS. A generation of so-called
technical approximations of the RT plans was therefore needed.
Clinical RT plans RT plan set including five IMRT (step-and-shoot) and five
VMAT clinical plans were selected from TYKS data. IMRT plans included either
single PTV or two PTVs. The simultaneous integrated boost (SIB) [90] with two
dose prescriptions was used in the case IMRT plans with two PTVs. Table 3.2 shows
an overview of selected cases and information relevant to the RT simulation process.
Table 3.2: An overview of the 10 patient cases selected for generation of technical
approximations of RT plans.
Case# Tumour VMAT/SRT IMRT Surgery SIB fixation
01 secondary - - - TM
02 secondary - - - TM
03 secondary - - - TM
04 primary - - TM
17 primary - TM
25 primary - TM
28 primary - TM
30 primary - - SRT-TM
38 primary - - TM
52 primary - - SRT-TM
RT planning process CT images with removed TM were here used as primary
images in the RT planning process. No further modifications were applied to these
CT images. LINAC parameters, gantry spacing, and CT-density table were selected
as identical to those employed in the PTV position dose analysis described above.
The spatial resolution of isotropic dose grid voxels was selected to be 2mm for IMRT
and 1mm in the case of VMAT plans. This selection was in agreement with original
clinical RT plan parameters apart from few exceptions.
Clinical RT structures stored in DICOM format were imported into the RT plan in
the TPS. In addition to PTV and OAR delineations, GTV, CTV, isodoses and other
auxiliary structures were usually available in each of the RT structure sets. Figure
3.16, therefore, shows examples including only a tiny fraction of contours, which were
involved in the RT simulation process. The presence of auxiliary structures (layers)
within the PTV was unique to the VMAT plans. These structures were used for
further dose escalation within the PTV in order to get as steep gradients around the
PTV as possible according to discussion with the TYKS oncologist.
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(a) (b) (c)
Figure 3.16: Examples of essential RT contours extracted from clinical data. RINGs
and normal tissue usually used as avoidance regions are displayed as green areas.
Contours for IMRT plan with single PTV (red) (a) and IMRT plan with simultaneous
integrated boost (SIB) into the second PTV (yellow) (b). Contours for VMAT plan
with one PTV (red) and auxiliary structures used for further dose escalation are
displayed within the PTV (c).
The beam or arc geometry and isocentres were imported into the TPS using
Pinnacle scripts. These scripts were generated by other script implemented in
MATLAB (Mathworks, USA) that was developed and kindly provided by Gregory
Bolard from Clinique de Genolier (Switzerland). The RT plan saved in DICOM
format was the only input required. Since this script was originally compatible with
VMAT RT plans only, a slight modification had to be applied in order to enable
import of IMRT beams into RT plans in Pinnacle. Both, coplanar and non-coplanar
arrangements of beams or arcs were used in selected RT plans.
Optimisation objectives The major challenge in the generation of clinical RT
plan approximations was the optimisation process as information about original plan-
ning objectives was not included in the original datasets. These objectives, therefore,
had to be estimated from the clinical dose distributions. This was accomplished
through calculation of label statistics, in a similar manner as done previously in the
case of bulk HU estimation as described in subsection 3.3.3. The main di erence was
that instead of using a CT image, the dose distribution volume was used where the
voxel intensity was given in Gy. Labels were generated from delineations of target
volumes, auxiliary structures and avoidance regions.
Dose calculation grid resolution defined the spatial resolution of the 3D dose
distribution. The mean dose values from PTV labels in the case of IMRT plans
and from labels of auxiliary structures in case of VMAT plans were then used as
dose prescription objectives in the TPS. Dose constraints were estimated based on
maximum and mean doses, which were calculated from avoidance regions and RING
labels. Dose recommendations listed in table 2.1 were taken into account in the RT
planning process as well. The auto-planning process using the DMPO algorithm [91]
was employed in the RT plan optimisation process, similarly as done for the PTV
position dose analysis. The auto-planning usually resulted in su ciently optimised
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VMAT RT plans on the first run, while several subsequent optimisation steps were
typically needed in case of IMRT plans in order to approximate PTV coverage by
95% isodose surface.
3.4.3 RT plan simulation on fCT images
RT plan recalculation Both simplified RT plans with spherical PTV and technical
approximation of clinical RT plans were simulated on all seven versions of the
generated fCT volumes listed in table 3.1. The plan simulation was done by copying
the optimised RT plan to the fCT image for dose calculation. Since the fCT image
in this evaluation is merely a segmented version of the CT image, there is no need
for image registration. All planning parameters and optimised objectives, therefore,
remained identical when one compared them to those of the reference CT-based
RT plan. Plan recalculation was accomplished using the Adaptive convolution
superposition algorithm [91] and the recalculation resulted in a new dose distribution
volume reflecting the intensity parameters of the fCT image.
Automated RT plan simulation The dose analysis presented in this thesis
required 490 RT plan simulations on fCT images. The analysis of such an amount of
plans was made viable only by implementing an automated RT plan recalculation
workflow. This automated workflow was implemented by Unix shell scripting that is
capable of running the Pinnacle TPS. The Pinnacle scripting was responsible for
an execution of the RT plan recalculations and subsequent planning data export.
Multiple DICOM server connections were established for the purpose of automated
data export from the Pinnacle virtual machine running on Solaris OS and also for
the subsequent data sorting in destination directories on the physical workstation
running the Microsoft Windows 10 OS. Diagram 3.17 shows the core principle of the
automated RT plan simulation workflow.
Figure 3.17: Diagram showing the principle of automated RT plan simulation on
fCT images and planning data export for further analysis.
3.5 Data evaluation methods
The evaluation methods employed in this thesis can be divided into two groups. The
first group consists of measures used for image quality assessment of the generated
fCT images. The second method group is dedicated to the RT planning quality
assurance and primarily to dose comparison methods.
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3.5.1 Image quality evaluation
The error between CT and fCT images can be quantified through a voxelwise com-
parison and summarised as for example the mean error (ME) or mean absolute error
(MAE) usually calculated within the entire FOV [48]. However, these metrics tend to
be lowered with increasing number of voxels filled with HU values corresponding with
those of water or air [43]. Abundant and from the analysis point of view uninteresting
background air voxels would, therefore, have a large impact on estimation of mean
errors. Consequently, all the mean errors were calculated only for those voxels located
within the patient volume. The binary head volume mask (see subsection 3.2.4)
was utilised in the calculation of average errors. Moreover, all the outlier voxels
(e.g. clips, calcification) were excluded from the error calculations. Mathematical
formulations for ME and MAE are
ME = 1
N
nÿ
i=1
fCTi ≠ CTi, (3.11)
MAE = 1
N
nÿ
i=1
|fCTi ≠ CTi| , (3.12)
where CTi is ith CT (reference) voxel and fCTi is ith fCT (comparison) voxel used
for the error estimation. Number N defines a number of voxels allocated inside of
the patient head volume with reduced FOV in order to exclude the neck region. ME
and MAE were individually estimated for all the fCTx-CT pairs of 10 patient cases
which were also used for purposes of bulk HU estimation and PTV position dose
analysis. The final mean errors were calculated for all the fCT versions from the
individual ME and MAE estimates. MAE and ME from the single tissue labels were
estimated in the same manner.
3.5.2 Dose comparisons
All the methods and metrics used in dose comparisons were handling the CT-based
dose calculation data as a reference, and the fCT-based dose recalculations were
handled as a comparison datasets. Dose comparisons were carried out for all the fCTx-
CT pairs using the outcomes from both PTV Position and technical approximation
of clinical RT plans as input data.
DVH analysis DVH graphs and statistics were estimated from PTVs and selected
OARs or RINGs covering the normal tissue in the case of PTV position analysis. The
composition of OARs varied case by case depending on availability of RT contours
and dose distribution coverage. The list of evaluated OARs corresponded with the
one from table 2.1. DVH statistics from a single PTV were evaluated in case of the
simplified VMAT RT plans (PTV position analysis) and basic IMRT RT plans. In
the event of clinical approximations of VMAT and IMRT-SIB RT plans, there were
always two PTV contours (PTV 1 and PTV 2) included in the DVH analysis. The
42
PTV 2 contour was already present in the original IMRT-SIB TYKS data. However,
the PTV 2 was in the case of VMAT RT plans generated from the auxiliary structure
which was in the clinical 3D dose distribution roughly covered by 95% isodose surface.
The role of PTV 2 was to capture dose escalations within the entire PTV volume
(PTV 1+PTV 2). DVH statistics including Dmean, D2%, D50%, D95%, D98% and V95%
were calculated from the PTV region. The ICRU conformity index (CI) was further
estimated for the simplified VMAT plans, where the CI is defined as
CI = TV
PTV
, (3.13)
where the treated volume (TV) was estimated to be the 95% isodose volume V95%.
The TV was calculated as the sum of V95 obtained from both, the PTV and the
RING. Percentual di erences of selected DVH statistics and CI between CT and
fCT images were calculated for the purpose of dose comparisons.
Gamma analysis The 3D gamma analysis was performed in this study using
a 1%/1mm passing criterion. The implementation of the fast gamma analysis
algorithm, earlier described by M. Wendling, et. al (2007), was employed in our
analysis [92]. This implementation used the global normalisation to the maximum
dose distribution point for the evaluation of  D criterion.
The dose distribution voxel percentage to pass the gamma criterion was deter-
mined to be 99%. The gamma statistics was calculated from the 75% isodose volume
covering high dose regions including the PTV and surroundings. Hence, a decision
whether the case passes the gamma criterion or not was made based on data from
this isodose volume.
Gamma and dose 3D distributions were generated from the entire patient volume
in order to get visual information from the less clinically relevant low dose regions as
well. The gamma analysis was selected because it allows for an objective passing
criteria which is convenient for evaluations. However, as there was no registration
misalignment between CT and fCT images, the DTA criterion might, therefore, be
of a lower significance. Hence, 3D dose di erence maps (CT - fCT) were generated
in addition to the gamma distributions.
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4 Results
4.1 Head volume mask
The initial step in generating a binary mask of the head was the removal of the
thermoplastic mask (TM). The TM removal was carried out using the combination of
intensity thresholding (≠250HU), connected component labelling and morphological
operations. The concept and an example of the result of this process are shown in
figure 4.1.
(a) (b) (c)
Figure 4.1: Removal of the thermoplastic mask (TM) from the CT image. Original
CT (a), identification of the patient volume and the TM components (b). Modified
CT after the TM component has been removed (c).
Holes inside of the binary mask were then filled using the anterior and posterior
masks generated through the active contour model. Any remaining holes were filled
using the 2D floodfill algorithm as described in subsection 3.2.4. An example of filled
binary head mask is shown in figure 4.2.
(a) (b) (c)
Figure 4.2: Binary volume mask of the head. Axial (a), sagittal (b) and coronal view
(c).
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4.2 Tissue stratification for MR-only RT
4.2.1 CT image segmentation
2D K-means clustering was employed in the tissue segmentation from CT images
using all the voxels with intensity higher than ≠500HU that were located within
the head mask. This clustering method used six classes where the two soft tissue
compartments (fat, water-rich tissue) were represented by one class each, and two
bone compartments were each divided into two classes. The silhouette coe cient of
0.64 (see equation 3.9) for this classification setup indicated good allocation of classes
among the voxel intensity distribution. The CT segmentation result displaying all
segmented tissue labels is shown in figure 4.3. A calcification label can also be seen
which was separated from the bone class by use of connected component labelling.
(a) (b) (c)
(d) (e) (f)
Figure 4.3: CT image (a-c) with K-means segmentation of the same CT image (4
labels) (d-e). There is shown an extra label for calcifications located in the central
part of the brain (f). Axial (a, d), sagittal (b, e) and coronal view (c, f).
4.2.2 MR image segmentation
The brain tissue segmentation was carried out on T1 MR image for voxels located
within the brain volume. This volume was obtained through skull stripping of the
registered CT image as presented in subsection 3.3.2. Figure 4.4 shows images
capturing the neighbourhood of tissue labels (CSF, WM, GM) that were acquired
from the initial K-means brain tissue segmentation (see subsection 3.3.2). These
images were the product of the 3D convolution between tissue labels and the 3D
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kernel using the 18 neighbouring voxels. An example of original T1 MR image is
compared to final MRI segmentation in figure 4.5. This segmentation expresses a
superior spatial agreement with the MR source image. The use of neighbourhood
information compensated the impact the relatively low and spatially inhomogeneous
SNR in some MR image cases.
(a) (b) (c)
Figure 4.4: Neighbourhood probability maps obtained by convolution of the tis-
sue labels with the 18 neighbourhood 3D kernel. These labels were derived from
the K-means initialisation. The CSF (a), grey matter (b) and white matter (c)
neighbourhood.
(a) (b) (c)
(d) (e) (f)
Figure 4.5: T1 weighted MR image (a-c) and corresponding MRF-ICM segmentation
(d-f) of the voxels located inside of the brain mask. This mask is denoted by the red
line in MR image (a-c). Axial (a, d), sagittal (b, e) and coronal view (c, f).
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4.3 Flattened CT images
4.3.1 Bulk tissue HU values
The FOV was cut in the inferior direction (see figure 4.6) in order to reduce the impact
of voxels not likely to be within the beam path on the bulk tissue HU estimation.
Table 4.1 shows the average HU estimates across all 10 patient CT images for all the
tissue compartments included in each fCT version. The average HU value for air
cavities (≠986HU) was identical to the value estimated for the background air.
The only tissue class whose HU varies over the di erent fCT versions is the "tissue"
class. However, this is simply because di erent voxels were included in this class
for many of the fCT versions. Firstly, in the case of fCT2 and fCT3 both fat and
water-rich tissue was included resulting in an HU value of 15. Secondly, fCT4 and
fCT5 tissue HU value was estimated only from the water-rich tissue label resulting
in a higher HU value of 47. And finally, in the case of fCT7 and fCT8, the mean
tissue value of 44HU was calculated from the water-rich tissue when excluding the
brain tissue labels (CSF, GM and WM).
(a) (b) (c)
Figure 4.6: The final segmentation including both, CT and MRI-based labels, with
reduced FOV in the inferior direction. The FOV reduction was undertaken for the
purpose of the bulk tissue HU estimation process. Axial (a), sagittal (b) and coronal
view (c).
Table 4.1: Mean HU values across all 10 patient CT images and corresponding
standard deviations estimated for tissue classes encompassed in particular fCT
configuration.
fCT2 fCT3 fCT4 fCT5 fCT7 fCT8
Air cavities - ≠986± 1.22 ≠986± 1.22 ≠986± 1.22 ≠986± 1.22 ≠986± 1.22
Fat - - ≠98± 11.87 ≠98± 11.87 ≠98± 11.87 ≠98± 11.87
Tissue 15± 9.69 15± 9.69 47± 5.04 47± 5.04 44± 6.91 44± 6.91
Bone 935± 113.98 935± 113.98 935± 113.98 - 935± 113.98 -
Spongy bone - - - 575± 46.24 - 575± 46.24
Compact bone - - - 1265± 86.95 - 1265± 86.95
CSF - - - - 16± 2.41 16± 2.41
White matter - - - - 41± 3.51 41± 3.51
Grey matter - - - - 53± 5.10 53± 5.10
47
4.3.2 Flattened CT visualisation
Figures 4.7 and 4.8 show a visual comparison of fCT8 with the CT image using a
bone- and tissue-intensity windowing, respectively. Both comparisons show a very
good visual agreement in bone and tissue spatial composition. Some di erences can
be observed though such as for the visualisation of calcification in the middle of the
brain as well as in the visualisation of the less dense bones such as C1.
(a) (b) (c)
(d) (e) (f)
Figure 4.7: A comparison of the CT image (a-c) with the fCT8 (d-f) using the bone
intensity window. Axial (a, d), sagittal (b, e) and coronal view (c, f).
(a) (b) (c)
(d) (e) (f)
Figure 4.8: A comparison of the CT image (a-c) with the fCT8 (d-f) using the soft
tissue intensity window. Axial (a, d), sagittal (b, e) and coronal view (c, f).
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4.3.3 Image quality evaluation
Mean absolute (MAE) and mean errors (ME) were calculated for all voxels located
within the binary mask with reduced brain FOV as presented in figure 4.6. The error
values are shown in table 4.2. The errors were further calculated within the single
tissue labels, and the results are shown in tables 4.3 and 4.4.
Table 4.2: Mean absolute errors (MAE) and mean errors (ME) in HU and standard
deviations from patient volume between fCT and CT images across all 10 patients.
fCT2 fCT3 fCT4 fCT5 fCT7 fCT8
MAE 134.79± 12.25 111.51± 11.39 90.41± 8.97 59.66± 3.91 90.37± 9.18 59.63± 4.15
ME 26.03± 28.45 ≠3.84± 24.36 ≠4.65± 25.24 ≠4.18± 14.76 ≠7.14± 25.17 ≠6.67± 14.64
Table 4.3: Mean absolute errors (MAE), and their standard deviations between fCT
and CT images in HU estimated within the tissue labels across all 10 patients.
fCT2 fCT3 fCT4 fCT5 fCT7 fCT8
Air cavities - 112.44± 9.81 112.44± 9.81 112.44± 9.81 112.44± 9.81 112.44± 9.81
Fat - - 47.68± 8.55 47.68± 8.55 47.68± 8.55 47.68± 8.55
Tissue 84.35± 9.80 53.76± 6.51 21.46± 1.76 21.46± 1.76 39.00± 2.61 39.00± 2.61
Bone 360.13± 34.17 360.13± 34.17 360.13± 34.17 - 360.13± 34.17 -
Spongy bone - - - 202.61± 21.39 - 202.61± 21.39
Compact bone - - - 187.16± 19.62 - 187.16± 19.62
CSF - - - - 27.32± 8.88 27.32± 8.88
White matter - - - - 10.47± 2.91 10.47± 2.91
Grey matter - - - - 14.68± 2.21 14.68± 2.21
Table 4.4: Mean errors (ME) and their standard deviations between fCT and CT
images in HU estimated within the tissue labels across all 10 patients.
fCT2 fCT3 fCT4 fCT5 fCT7 fCT8
Air cavities - ≠110.39± 9.95 ≠110.39± 9.95 ≠110.39± 9.95 ≠110.39± 9.95 ≠110.39± 9.95
Fat - - ≠0.20± 11.87 ≠0.20± 11.87 ≠0.20± 11.87 ≠0.20± 11.87
Tissue 32.85± 14.41 0.34± 9.69 ≠0.46± 5.04 ≠0.46± 5.04 0.13± 6.91 0.13± 6.91
Bone ≠0.49± 113.98 ≠0.49± 113.98 ≠0.49± 113.98 - ≠0.49± 108.14 -
Spongy bone - - - 0.40± 46.24 - 0.40± 46.24
Compact bone - - - ≠0.16± 86.95 - ≠0.16± 86.95
CSF - - - - ≠24.96± 9.64 ≠24.96± 9.64
White matter - - - - ≠4.70± 4.16 ≠4.70± 4.16
Grey matter - - - - ≠1.92± 4.79 ≠1.92± 4.79
MAE from the head volume (see table 4.2) decrease with increasing number
of tissue compartments up to fCT5 configuration (except the fCT7). MAE shows
the significant impact ( MAE = ≠21.10HU) of soft tissue stratification into the
fat and water-rich tissue (fCT3 vs. fCT4). The bone stratification into two bone
compartments (fCT4 vs. fCT5) resulted in the even higher di erence of ( MAE =
≠30.75HU). However, the brain stratification had very low impact on MAE results
( MAE = ≠0.03HU).
ME values served for the verification of the correct bulk HU assignment to
segmented labels. The low but non-zero ME values in tables 4.2 and 4.4 were the
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result of the rounding of calculated HU values into integers as well as the result of
using modified methods for the bulk HU estimation for the CSF, GM, WM, and air
cavities (see subsection: 3.3.3). Table 4.4 with ME from single tissue labels shows
very low errors for those tissues segmented directly from the CT image. An exception
was the fCT2, where the air cavities were filled with the soft tissue bulk HU value
(15,HU), and this is in turn resulted in larger ME of 32.85HU.
For the visual evaluation of the fCT images were in addition to the MAE and ME
generated fCT-CT HU di erence maps (see figure 4.9). There can be observed the
impact of adding the air cavities (fCT2 vs. fCT3), fat tissue class (fCT3 vs. fCT4)
and bone classes (fCT4 vs. fCT5 and fCT7 vs. fCT8). The impact of the brain
tissue stratification (fCT4 vs. fCT7 and fCT5 vs. fCT8) was visually negligible.
(a)
300
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0
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(b)
(c)
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(d)
(e)
300
150
0
150
300
(f)
Figure 4.9: fCT versions and fCT-CT HU di erence maps. Depicted are fCT2 (a),
fCT3 (b), fCT4 (c), fCT5 (d), fCT7 (e) and fCT8 (f). Colorbars show di erence
scale in HU.
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4.4 PTV position analysis
4.4.1 Simplified radiotherapy plans
Simplified RT plans with spherical PTVs in six locations for each patient were created
for the purpose of PTV position dose analysis. The primary aim of the RT plan
optimisation was to achieve a PTV coverage by the 95% isodose volume while
maintaining steep gradients around the PTV. An example of such a simplified plan
is shown in figure 4.10.
PTV
95%
90%
80%
70%
60%
50%
40%
30%
20%
10%
Figure 4.10: An example of an optimised simplified RT plan with the PTV (seen as a
faint red line barely outside the orange 95% isodose volume) in superior-central (SC)
location. Isodose volumes normalised to the maximum dose point are colour-washed
(e.g. 95% isodose volume - orange).
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4.4.2 DVH analysis
DVH statistics and graphs were calculated for PTVs and RINGs overlaid on dose
distributions that were obtained from the optimised CT and fCT-based RT plans.
An example of the cumulative DVH for the PTV in the SC position is shown in
figure 4.11. This graph shows the reference CT in comparison with fCT8 and fCTw.
While the fCT8 shows a very small di erence in both PTV and RINGs (less than
0.5%), the fCTw shows a di erence in the range between 2% and 3% in comparison
with the CT. Dose di erences of such ranges were observed in multiple DVH points
as it is shown in tables 4.5 and 4.6 presenting the percentage di erences in selected
DVH point statistics.
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Figure 4.11: An example of DVH from the PTV position dose analysis for the PTV
SC position. The di erence between CT, and fCT8 (dashed) and fCTw (dotted).
Table 4.5: Mean percentual di erence (fCT-CT) of DVH statistics in the PTV for
single fCT versions in all the PTV position. Statistics are estimated from 60 fCT-CT
RT plan pairs for each fCT version (420 RT dose comparisons in total).
fCTw fCT2 fCT3 fCT4 fCT5 fCT7 fCT8
 Dmean 2.70± 0.65 0.35± 0.43 0.47± 0.37 0.18± 0.38 0.05± 0.21 0.25± 0.38 0.12± 0.21
 D2% 2.82± 0.67 0.41± 0.42 0.49± 0.37 0.20± 0.37 0.06± 0.21 0.26± 0.38 0.12± 0.21
 D50% 2.72± 0.66 0.36± 0.43 0.49± 0.38 0.18± 0.37 0.05± 0.21 0.25± 0.38 0.12± 0.21
 D95% 2.50± 0.64 0.23± 0.42 0.38± 0.37 0.19± 0.37 0.06± 0.21 0.25± 0.38 0.12± 0.21
 D98% 2.37± 0.62 0.21± 0.41 0.37± 0.38 0.19± 0.37 0.06± 0.21 0.25± 0.38 0.12± 0.21
 V95% ≠0.19± 0.37 ≠0.28± 0.29 ≠0.34± 0.13 0.06± 0.13 0.04± 0.11 0.04± 0.12 0.02± 0.12
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Table 4.6: Mean percentual di erence (fCT-CT) of DVH statistics for RINGs covering
the normal tissue for single fCT versions in all the PTV positions. Statistics from 60
fCT-CT RT plan pairs for each fCT version (420 RT plan comparisons in total).
fCTw fCT2 fCT3 fCT4 fCT5 fCT7 fCT8
 Dmean 2.38± 0.65 0.37± 0.37 0.47± 0.33 0.17± 0.34 0.00± 0.28 0.24± 0.34 0.06± 0.28
 Dmax 3.18± 0.77 0.41± 0.56 0.37± 0.34 0.19± 0.34 0.06± 0.18 0.23± 0.34 0.10± 0.17
 D50% 2.19± 0.62 0.38± 0.37 0.49± 0.30 0.15± 0.31 ≠0.01± 0.26 0.22± 0.31 0.06± 0.26
 D90% 2.17± 1.10 0.47± 0.35 0.58± 0.35 0.27± 0.48 ≠0.12± 0.86 0.35± 0.48 ≠0.05± 0.86
Mean di erences of statistics in selected DVH points were evaluated based on both
fCT version and the PTV position. In general, there were some low, but nevertheless
substantial trends. Figure 4.12 shows results for Dmean and D95% DVH points.
An impact of the PTV position is evident only in the case of cerebellar position
(CR) where can be observed the clear e ect of adding the air cavities (fCT2 vs. fCT3).
The superior fCT2 performance can be explained in the way that both, missing air
cavities (filled by soft tissue bulk HU) and fat classes cancelled each other out, while
this was not the case of the fCT3 which already includes the air cavity compartment.
All the other trends are related rather to the fCT configuration (HU assignment).
There is a clear impact of the tissue stratification into the water-rich tissue and fat
(fCT3 vs. fCT4). The noticeable e ect of splitting the bones into two compartments
is visible as well. There was not detected a significant impact of the brain tissue
stratification (fCT4 vs. fCT7 and fCT5 vs. fCT8).
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Figure 4.12: Selected DVH statistics for all the CT versions based on the PTV
location. The mean di erences and standard deviations between fCT and CT-based
RT plans were obtained using all 10 patient cases.
The PTV conformity index (CI) which is described in subsection 3.5.2 was
evaluated in the same manner, and the result can be observed in figure 4.13. The
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dose conformity was regarding the PTV position a ected only in the case of anterior
(A) location. Here, adding of air cavities (fCT2 vs. fCT3) resulted in a decrease of
the standard deviation. There can be seen a clear impact of the soft tissue and bone
stratification that are more pronounced in comparison with figure 4.12.
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Figure 4.13: Mean di erences and standard deviations of conformity index (CI) for
all the CT versions across the PTV locations.
In the high and median dose (D50%) regions, the behaviour of the dose in the
RINGs (see 4.14) showed similar trends as for the PTVs. The low dose regions D90%
show high standard deviations which combined with the low absolute dose values
indicate the dose di erences to be at the noise level.
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Figure 4.14: Selected DVH statistics for RINGs covering the normal tissue divided
by PTV location.
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4.4.3 Gamma analysis and dose di erence distributions
The 1%/1mm 3D gamma statistics (see subsections 2.4.2 and and 3.5.2) calculated
from the 75% isodose volume are presented in table 4.7. 59 from 60 fCTw cases
failed the criterion of 1%/1mm using the 99% passing fraction, whereas all fCT5
and fCT8 cases passed this criterion. The passing rate increased by adding the inner
air class (fCT2 vs. fCT3), tissue (fCT3 vs. fCT4) and bone stratification (fCT5 vs.
fCT8). The brain tissue stratification (fCT5 vs. fCT8) did not significantly influence
the gamma passing rate and overall gamma statistics.
Table 4.7: Gamma statistics from 75% isodose volume for single fCT versions from
all the PTV positions.
fCTw fCT2 fCT3 fCT4 fCT5 fCT7 fCT8
# failures 59/60 12/60 9/60 3/60 0/60 4/60 0/60
pass. vol. [%] 52.71 96.70 96.88 99.51 100.00 99.15 100.00
median “ 1.12 0.22 0.23 0.17 0.10 0.19 0.11
max. “ 3.00 0.80 0.74 0.59 0.36 0.62 0.38
Figures 4.15, 4.16, 4.17 and 4.18 show examples of absolute gamma (1%/1mm)
index and dose di erence distributions for cases where the inner air, tissue, bone and
brain stratifications had the largest local impact on the gamma passing rate.
Identified gamma analysis failures were caused by absence of air cavities (figure
4.15), insu cient soft tissue stratification (4.16), and bone stratification (4.17). The
standalone brain tissue stratification (fCT5 vs. fCT8) did not cause any gamma
failures among all the 420 dose comparisons.
|γ| 
fCT3fCT2 fCT3fCT2
ΔD [Gy]
Figure 4.15: An example of the local impact of air cavities (fCT2 vs. fCT3). Gamma
distributions (left) and dose di erence maps (right).
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|γ| 
fCT4fCT3
ΔD [Gy]
fCT4fCT3
Figure 4.16: An example of the impact of the soft tissue stratification (fat, water-rich
tissue) (fCT3 vs. fCT4). Gamma distributions (left) and dose di erence maps (right).
|γ| 
fCT5fCT4
ΔD [Gy]
fCT5fCT4
Figure 4.17: An example of the local impact of the bone stratifications (spongy bone,
compact bone) (fCT4 vs. fCT5). Gamma distributions (left) and dose di erence
maps (right).
|γ| 
fCT8fCT5
ΔD [Gy]
fCT8fCT5
Figure 4.18: An example of a very low impact of the brain tissue stratifications (CSF,
grey matter and white matter) (fCT5 vs. fCT8). Gamma distributions (left) and
dose di erence maps (right).
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4.5 Technical approximations of clinical RT plans
4.5.1 Radiotherapy plans
Five IMRT and five VMAT technical approximations of RT plans were generated
using clinical PTV and OAR delineations. The purpose of this step was to verify
the outcomes of the PTV position dose analysis using clinical-like RT plans. The
primary aim of the RT plan optimisation was to achieve PTV coverage by the 95%
isodose volume while maintaining steep gradients around PTV. Figures 4.19 and
4.20 show examples of optimised IMRT and VMAT RT plans.
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Figure 4.19: An example of optimised technical approximation of the IMRT RT plan
with single PTV (red outline). Isodose volumes normalised to the maximum dose
point are colour washed (e.g. 95% isodose volume - orange).
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Figure 4.20: An example of optimised technical approximation of the VMAT RT
plan with complex PTV shape displayed as two separate units in the sagittal plane
(superior and inferior delineations). PTV 1 is in each of these PTV units represented
by the outer red layers. The PTV 2 (generated from the auxiliary structure), that is
roughly covered by 95% isosurface (orange), is highlighted by the inner red layers.
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4.5.2 DVH analysis
Figure 4.21 shows an example of the cumulative DVH for the VMAT RT plan from
figure 4.20. This graph displays the reference CT in comparison with fCT8 and
fCTw. While the fCT8 shows a very low di erence in both PTVs (less than 0.5%),
the fCTw shows a di erence in the range between 2% and 3% that is very similar to
that seen for the simplified RT plans with spherical PTVs in Fig. 4.11. This level
of dose di erence is seen to be typical when looking at tables in 4.8 and 4.9 where
the percentage di erences in the selected DVH point statistics for PTV 1 and PTV
2 are given. The significant change was in comparison with PTV position analysis
observed in  V95% for the PTV 1 where the tissue stratification (fat, water-rich)
caused a 4.14% decrease.
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Figure 4.21: An example of DVH from the technical approximation of the clinical
VMAT RT plan. The di erence between CT, and fCT8 (dashed) and fCTw (dotted).
Table 4.8: Mean percentual di erence (fCT-CT) of DVH statistics for clinical PTV 1
in all the fCT versions
fCTw fCT2 fCT3 fCT4 fCT5 fCT7 fCT8
 Dmean 2.61± 1.10 0.27± 0.58 0.36± 0.53 0.29± 0.42 0.15± 0.18 0.34± 0.43 0.19± 0.19
 D2% 3.20± 1.07 0.49± 0.59 0.57± 0.51 0.45± 0.48 0.27± 0.32 0.42± 0.48 0.32± 0.31
 D50% 2.67± 1.09 0.25± 0.59 0.35± 0.53 0.29± 0.42 0.15± 0.19 0.34± 0.43 0.19± 0.20
 D95% 2.01± 1.23 0.06± 0.82 0.13± 0.81 0.05± 0.77 ≠0.08± 0.67 0.09± 0.77 ≠0.03± 0.68
 D98% 1.71± 1.42 ≠0.08± 1.05 ≠0.02± 1.01 ≠0.05± 1.02 ≠0.16± 0.89 ≠0.01± 1.02 ≠0.11± 0.90
 V95% ≠6.52± 10.96 ≠6.28± 5.03 ≠5.15± 6.30 ≠1.01± 4.68 0.74± 4.65 ≠2.24± 3.96 0.44± 3.95
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Table 4.9: Mean percentual di erence (fCT-CT) of DVH statistics for clinical PTV
2 in all the fCT versions
fCTw fCT2 fCT3 fCT4 fCT5 fCT7 fCT8
 Dmean 2.70± 1.02 0.26± 0.54 0.33± 0.52 0.24± 0.42 0.14± 0.18 0.29± 0.42 0.19± 0.18
 D2% 3.20± 1.03 0.37± 0.51 0.40± 0.51 0.29± 0.42 0.18± 0.20 0.34± 0.41 0.23± 0.18
 D50% 2.69± 1.05 0.28± 0.54 0.34± 0.52 0.26± 0.42 0.15± 0.18 0.30± 0.42 0.20± 0.18
 D95% 2.40± 1.08 0.13± 0.58 0.21± 0.57 0.17± 0.46 0.11± 0.22 0.22± 0.47 0.15± 0.23
 D98% 2.24± 1.21 0.09± 0.59 0.17± 0.60 0.16± 0.47 0.09± 0.24 0.19± 0.48 0.13± 0.25
 V95% ≠0.17± 0.29 ≠0.04± 0.11 0.16± 0.68 ≠0.01± 0.05 ≠0.01± 0.03 ≠0.01± 0.04 0.00± 0.02
Figure 4.22 shows how is the  Dmax for OARs in relation to the fCT versions. A
substantial decrease in both  Dmax and standard deviation values can be observed
with an increasing number of tissue compartments. However, the absolute dose
values were very low especially in the case of VMAT plans, and therefore even the
small change in dose may indicate a relatively large, however, clinically not relevant
impact.
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Figure 4.22: Changes in maximum dose in OARs with di erent fCT versions.
4.5.3 Gamma analysis and dose di erence distributions
The gamma statistics calculated from the 75% isodose volume is presented in table
4.10. All 10 fCTw cases failed the criterion of 1%/1mm with 99% gamma passing
fraction, whereas all fCT5 and fCT8 images passed the analysis. The passing rate
increased by adding the inner air cavity class (fCT2 vs. fCT3) and bone stratification
(fCT5 vs. fCT8). The brain tissue stratification (fCT5 vs. fCT8) did not significantly
influence the passing rate or other gamma statistics.
Table 4.10: Gamma statistics from 75% isodose volume for single fCT versions.
fCTw fCT2 fCT3 fCT4 fCT5 fCT7 fCT8
# failures 10/10 3/10 2/10 2/10 0/10 2/10 0/10
pass. vol. [%] 55.81 98.76 99.01 99.51 99.93 99.50 99.93
median “ 0.96 0.18 0.19 0.15 0.10 0.16 0.11
max. “ 6.29 3.44 2.10 2.06 1.78 2.09 1.77
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Figure 4.23 shows examples of absolute gamma (1%/1mm) index and dose
di erence distributions from the IMRT plan for fCTw and fCT8 of the same patient.
There is a noticeable impact of the metallic skull clip which has a high intensity
(> 2000HU) in the original CT image. Figure 4.24 shows an example of the bone
stratification impact (fCT4 vs. fCT5) on the gamma passing rate. Two axial slices
of the same patient are displayed.
(e) (f)(d)
(a) (b) (c)
|γ| ΔD [Gy]
Figure 4.23: A comparison of gamma distributions (b, c) and dose di erence maps
(a, e) for fCTw (a) and fCT8 (d) with respect to the reference CT image. Gamma
and dose distributions for fCTw (b, e) and fCT8 (c, f). A metallic skull clip with
high HU value in the original CT (not shown) can be seen to impact the dose and
gamma distributions.
|γ| 
fCT4
(b) (c) (d)(a)
fCT5 fCT4 fCT5
Figure 4.24: An example of bone stratification impact (fCT4 vs. fCT5) on gamma
distribution. Displayed are two slices (a, b) and (c, d) from the same patient.
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5 Discussion
The primary aim of this study was to figure out what tissues need to be classi-
fied/segmented and assigned separate HUs for the dose accuracy to be su cient in
the MR-only workflow for brain tumour treatment. Understanding which tissues need
to be clearly visible is important when choosing the MR scan sequence to be used as
input for pCT generation, because the MR image quality will directly impact the
reliability of the tissue classification. To avoid confounding e ects such as CT-MR
fusion error, flattened CT images were used for comparison against the original CT
images, thereby ensuring that only the tissue stratification a ects the RT planning
accuracy.
The presented analysis was divided into two broad categories, both essential for
meeting the goals of this study. The first category includes steps that were needed
for the flattened CT generation. These steps comprised the head mask generation,
3D image segmentation and the bulk tissue HU estimation. The second and most
detailed part of this study included the generation of both simplified and clinical-like
RT plans followed by the execution of comprehensive dose comparisons between RT
plans calculated on CT and fCT images.
5.1 Flattened CT images
5.1.1 Head volume mask
The binary head mask was an essential component for several aspects of this study.
In a first step, the thermoplastic mask (TM) was removed from the image by a
combination of morphological operation with the connected component labelling. The
presented algorithm was, however, not satisfactory for eliminating the positioning box
and specific TM that are used in the frameless SRT. Nonetheless, only two patients
with the frameless SRT fixation devices were included in this study, and hence, the
use of manual image post processing was acceptable. No literature references could
be found with regards to TM removal, however, it was found to be an essential step
to e.g. enable correct functionality of the hole filling algorithms that were employed
in the head mask generation process. Moreover, the removal of the TM or other
objects in CT image background guaranteed that only the patient volume influenced
dose calculations.
The process of head mask generation was accomplished by the filling of the air
cavities. Nevertheless, conventional algorithms for the binary hole filling failed as air
cavities, and auditory canals were represented as open holes in the 3D space. An
alternative solution could have been the use of the 2D floodfill algorithm, separately
in all three anatomical planes, by handling single slices as 2D images. Another
alternative could be morphological image closing. These solutions would likely have
been adequate for filling the nasal cavities, nevertheless, both alternatives would su er
from e.g. incorrect overfilling within and behind the ear lobes. Literature reports
describing comprehensive algorithms dedicated to the 3D hole filling were also found
[93]. However, an implementation of advanced 3D pattern recognition algorithm
would be beyond the scope of this thesis with no clear benefits. Consequently, a
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di erent and more pragmatic solution to this problem was pursued. The fundamental
idea was to use an active contour model for the generation of artificial plasters
by taking advantage from the balloon-like behaviour of active contours (snakes)
[94]. These contours were then used to close the 3D holes, allowing the flooodfill
algorithm to fill the air voxels. Active contour models have previously been used for
the segmentation of e.g. brain tumours [95] from MR images and brain tissues [96]
or nasal cavities [97] from CT images, but has seemingly not been previously used
for 3D hole filling.
5.1.2 Tissue stratification for MR-only RT
Tissue stratification was the second step in the fCT generation process. Tissue
labels were segmented from both CT and MR images. The segmented tissues were
determined either based on the CT density or MRI contrast allowing for fairly simple
segmentation techniques to be used that can hopefully be at least partially reused
for pCT generation from MR images only. The classification methods were selected
based on their convenience for 3D image segmentation that can be a computationally
demanding process.
Conventional K-means clustering was, therefore, used for CT image segmentation
as it provided excellent classification outcomes even with relatively short compu-
tational times that were further reduced by clustering only voxels within the head
mask. Moreover, the use of K-means clustering has been previously reported for
segmentation of e.g. brain tumours from CT images [98]. The 2D K-means clustering
with original and median intensity features used in this thesis was previously reported
to have superior bone segmentation results for CT-liver images in comparison with
other classification methods such as 1D Fuzzy C-means and 1D K-means [78, 79].
Accurate skull segmentation in pCT generation is crucial because bones and other
dense structures have a larger impact on IMRT planning outcome than accurate soft
tissue classification [53].
The final CT segmentation was visually compared with the original CT image
in all three anatomical planes (see figure 4.3). The result shows very good spatial
agreement in the segmentation of large and connected structures. The median feature
was sometimes responsible for lower sensitivity in detecting small clusters such as
calcifications, fat drops and thin skin regions. However, the median image helped deal
with partial volume e ects and noise which resulted in smoother and more anatomical
CT image simulation. The alternative method for the CT segmentation could be,
for example, image intensity thresholding. The literature investigating the threshold
values for extracting bones [99] and air [77, 100] was studied and findings were applied
for e.g. extracting the air cavities by intensity thresholding (-500 HU). However, a
pure threshold based estimation for fat, water-rich tissue and bone compartments
would be problematic as each CT scanner has its own CT-density calibration tables.
Moreover, direct thresholding cannot be utilised for pCT generation from MR images.
Brain tissue labelling (CSF, WM and GM) was performed using the MRF-ICM
classification algorithm taking the T1 MR image as the input. This segmentation
method was selected as the Markov random field (MRF) takes the voxel neighbour-
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hood to the account when estimating the voxel tissue probability [64, 101]. The
information from surrounding voxels was helpful due to the relatively low and spatially
not consistent SNR in MR images [83]. Although, the MRF-ICM is a computationally
demanding method, the reduction of both the iteration count and the segmentation
VOI, by applying the skull stripping, enabled e cient implementation even for the
3D brain volume segmentation.
The classification directly from the CT image was considered as the alternative
solution for the brain tissue segmentation. However, this approach provided labels
reflecting the voxel intensity distribution in CT image, which is highly influenced
by noise and partial volume e ects, rather than the real anatomical information
as seen in the MR image. Anatomically more correct labels segmented from the
MR image might, however, be responsible for potentially higher di erences in both
image quality measures and dose comparisons where the CT image is usually the
reference or even the gold standard. This was taken into account for the bulk HU
tissue estimations that are discussed in the following subsection of this chapter.
5.1.3 Bulk tissue HU values
The pCT generation with bulk CT number assignment has been previously reported
in literature. However, these methods mostly used dual (bone and water/tissue) or
triple bulk (bone, water/tissue and air) HU assignment [5, 54, 64, 102]. This finding
further encouraged the use of fCT images with up to eight tissue compartments for
dose comparisons presented by this study.
In the present study, bulk HU values were estimated as averages from the seg-
mented tissue labels applied to the CT image. Resulting bulk HU values (see table
4.1) were calculated from the cohort of 10 patients. The final bulk HU values esti-
mated from all 10 patients were ≠98, 935, 575 and 1265HU for fat, average bone,
spongy and compact bone respectively. Varying values between 15 and 47HU were
estimated for the soft tissue as its tissue label coverage di ered from one fCT version
to the other.
Factors including partial volume e ects and noise within the brain tissue in the
CT image required the methods used for bulk HU estimation to be slightly di erent
(see subsection 3.3.3). Brain tissue (CSF, WM, GM) HU values were thus calculated
from eroded MR-image-based tissue labels applied to the CT image. The HU value
for air cavities was calculated from all image voxels (including background) with
intensity below ≠500HU. These methods resulted in the CT number of ≠986HU
for air cavities and of 16, 41 and 53 for CSF, WM and GM, respectively.
The ROI-based approach introduced by J. Korhonen et. al (2014), who picked
small circular ROIs for the bulk tissue HU estimation in the pelvic CT image
[103], was considered as the alternative method for brain tissue bulk HU estimation.
Nevertheless, this approach was not selected as the correct ROI allocation would be
a challenging task providing biased outcomes in the case of grey and white matter
HU estimation.
Electron density values, that can be found in ICRU report 46 (1992), are for
adipose tissue, brain and whole adult cranium reported to be 0.92, 1.04 and 1.61 g/cm3
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[104]. Converting these values using our CT-density calibration table yielded HU
values of ≠75, 36, and 971HU for fat, brain and whole cranium, respectively. These
values can be roughly compared with our bulk HU estimates (see table 4.1). The
CT number for fat (≠98HU) is in our case lower as the possible result of partial
volume e ects from the air that resulted in the local faulty voxel classification into
the fat class. The CT number for the brain (36HU) is not far from our estimation
of 42 ± 2HU, which was here calculated as a weighted average of the CSF, WM,
and GM class using the voxel counts as weights. The CT number for entire cranium
(971HU) is in excellent agreement with our bulk HU estimation for average cranial
bone (935HU).
These comparisons give validity to our bulk tissue HU estimates that are, con-
sidering the standard deviation values, in very good agreement with CT numbers
that were converted from the tissue electron densities obtained the ICRU report 46
(1992).
5.1.4 Flattened CT quality assurance
Visual comparison of the fCT images to the original CT image (viz figures 4.7 and
4.8) showed some di erences such as calcifications not being represented and less
dense bone is di erently visualised in the fCT images.
The more objective MAE analysis showed the real (absolute) di erence in the
voxel HU values, whereas the ME analysis demonstrated the average HU di erence
within the entire patient volume. The ME should, thus, ideally be approximately
zero as the result of the relative compensation between positive and negative HU
di erences in single voxels. This was also the case for fat, water-rich and bone
tissue classes. The exception was the fCT2 version with an ME of 32.85HU for the
water-rich tissue caused by high HU di erences within the air cavities that were filled
by bulk HU of tissue. The di erent methods employed in the voxels choice for the
HU estimation resulted in higher ME values in the case of air (≠110.39HU), CSF
(≠24.96HU), WM (≠4.70HU) and GM (≠1.92HU). The smallest MAE and ME of
59.63 and ≠3.97HU from entire patient volume were estimated for the fCT8 and
fCT3.
The particularly high CSF ME is likely simply a result of a larger ratio of CSF
voxels compared to all CSF voxels being on the border of the CSF class. The larger
relative mismatch of voxels between HU determination and ME calculation, the
larger the ME will be. For air, the HU di erence to the partial volume voxels is huge.
Even though the total amount of partial volume voxels compared to total air voxels
may not be large, the fact that the jump is from ≠986 HU to ≠95 HU for fat or
≥ 40 HU for tissue will cause a comparatively large ME. The principle applies for
bone, but there the voxels used for HU estimation and ME calculation are the same
which is why the ME is small.
The comparison of the here obtained ME and MAE with values reported in
literature is challenging due to varying approaches used for the error calculation
[43]. Furthermore, our fCT images do not su er from spatial distortions inherent to
the MRI and CT-MR image registration errors as is the case for real pCT images.
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Our fCT images further captured all bore holes and resections in the skull. The
accurate prediction of surgical incisions can not be achieved in e.g. the pCT images
predicted by conventional atlas-based methods without the use of dedicated post-
processing steps. However, robust and reliable reconstruction of such pathologies
may be challenging even for voxel-based methods. The impact of the skull resections
on dose calculations should be, therefore, the subject of the further research.
5.2 Dose analysis
5.2.1 Radiotherapy planning
In total, 70 CT-based RT plans including 60 simplified plans with spherical PTV and
10 technical approximations of clinical RT plans were optimised in the Pinnacle 16
TPS. These RT plans were then simulated on all seven fCT configurations (fCTw -
fCT8). The dose analysis thus stands on solid base counting 560 RT plans generated
for 17 CT images (70 RT plans) and simulated on from them derived fCT images (490
RT plans). Overall, 136 DICOM series were employed in presented dose analysis.
Simplified RT plans were calculated on modified CT images without TM, where
calcifications were replaced by water HU and voxels with unnaturally high HU values
(artefacts) were replaced by compact bone HU. This was done to guarantee that
only tissues and structures considered for the prospective pCT image had an impact
on dose comparisons.
Technical approximations of clinical plans were, however, calculated on the original
CT images, but without the TM, positioning boxes and patient couches. No further
changes were in this case applied to the CT images as the main goal for the technical
approximations of the clinical plans was to mimic the real clinical plans as closely as
possible.
In both RT plan categories, the primary optimisation objective was set to obtain
a PTV coverage of the 95% isodose surface with steep dose gradients around the
PTV.
5.2.2 Dose comparisons
The PTV position dose analysis provided the majority of the data in this study,
whereas the technical approximation of clinical RT plans was used to verify and
supplement the outcomes of the dose comparisons. The fCT performance was assessed
by DVH and the gamma analysis which are both standard methods commonly
employed in dose comparisons and pCT quality assurance in general.
The convenience of the DVH analysis lies in simple interpretation of the results
through 2D histograms that are ideal for comparing multiple dose distributions.
Additionally, the DVH statistics is beneficial for making conclusions from large
datasets. Nevertheless, DVH analysis does not capture the spatial information
and due to the averaging e ects may overlook local, though possibly important
di erences in dose distributions. Gamma analysis was therefore used to compliment
the DVH analysis as the generation of 3D gamma index distributions provides spatial
information of clinically relevant dose di erences. Visual inspection of the gamma
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index distributions was facilitated by showing corresponding 3D dose di erence maps
side by side.
Both DVH graphs and statistics such as Dmean, D2%, D50%, D95%, D98% and
V95% showed mean percentage di erences in the range of 2 - 3% in the case of fCTw
serving as the reference. Hence, the fCTw was excluded from any further evaluation.
Substantial di erences, though not exceeding 1% were observed for both PTVs and
RINGs in all the remaining fCT configurations. The DVH point statistics did not,
with a few exceptions, show substantial dependency on PTV position (see subsection
4.4.2). However, there was a substantial di erence in the DVH statistics among the
fCT configurations. Dose di erences in the range of up to 0.5% were observed in the
case of the fCT2 and fCT3 for both PTVs and RINGs. The fCT2 and fCT3 were the
only cases where the dose di erence varied slightly based on the PTV positioning.
This is likely due to the absence of fat and air cavities compartments as well as the
particular soft tissue HU assignment applied in fCT2. The fat compartment inclusion
(fCT3 vs. fCT4) resulted in a dose accuracy improvement of up to 0.20%. The bone
stratification (fCT4. vs. fCT5 and fCT7 vs. fCT8) further introduced a substantial
0.15% decrease in the overall percentual DVH statistics di erence. DVH analysis,
however, did not prove any benefits from the brain tissue stratification (fCT5 vs.
fCT8 and fCT4 vs. fCT7). The technical approximations of the clinical RT plans
showed mostly similar trends as observed in the PTV position dose analysis. Here,
the fCT configurations were shown to not have a clinically very significant impact
on maximum dose in OARs (see figure 4.22).
Simulation of multiple PTV positions in connection with a large number of dose
comparisons helped to identify rare, but important local gamma analysis failures
caused by insu cient tissue stratification. More importantly, all the observed failures
were eliminated by upgrading the number of stratified tissue compartments. This
claim was numerically confirmed by gamma failure counts (see tables 4.7 and 4.10)
where both, fCT5 and fCT8 passed the 1%/1mm gamma analysis criterion in all 70
dose comparisons. There were identified gamma failures arising from the absence of
air cavities, fat and bone stratifications, and gamma and dose di erence distribution
examples were shown in subsection 4.4.3. The brain tissue segmentation (fCT5 vs.
fCT8) did not improve the dose comparison results in any significant manner.
Technical approximations of the clinical RT plans unveiled the local gamma
failures arising from high HU di erence skull clip that was in fCT5 and fCT8 filled
with the compact bone HU value. This observation might be an obstacle for the
MR-only RT workflow, as MR imaging by its very nature does no allow visualisation
of metallic objects. Moreover, such objects are the common cause of severe artefacts
and distortions in MR images. We can also speculate that the absence of surgical
incision in, e.g., the atlas-based pCT images might result in local gamma failures in a
similar manner as was shown in our skull clip example. Furthermore, the craniotomy
seems to be, according to the TYKS data nature (see figure 3.2, and table 3.2)
as well as the literature reports [14], commonly used in brain tumour treatment.
Consequently, the impact of skull resections should be subject to further research.
Both DVH and gamma analyses results indicated an improved RT planning
accuracy when increasing the number of the stratified tissue compartments in the
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fCT images (up to the fCT5). When neglecting the evident change of fCTw vs.
fCT2, the largest improvements were observed in the case of soft tissue (fCT3 vs.
fCT4) and of the bone stratification (fCT4 and fCT5). The brain tissue stratification
(fCT7 and fCT8), however, did not show any significant impact on the RT planning
accuracy for the here studied cohort of 10 patients, and therefore, its only benefit
might be restricted to the inclusion of the anatomical information about the brain
structure. Both, DVH and gamma analysis results, therefore, identified the fCT5
including five tissue compartments (air cavities, fat, water-rich tissue, spongy and
compact bone) together with fCT8 with the brain tissue also stratified as the most
appropriate tissue segmentations for the MR-only RT workflow for the brain tumour
treatment.
The overall results are in agreement with those reported in literature where
di erences in DVH points (PTV) were between 0.3 and 2% [5, 6, 10, 64]. Moreover
100% gamma (1%/1mm) passing rate was reported for the PTV in the MR-only
workflow for brain [6]. DVH analysis results for adding the air cavities and fat label
further confirmed (fCT2. vs fCT3 and fCT3 vs. fCT4) the theory presented by
Edmund et. al (2014) that assigning the correct average amount of tissue to the
pCT may have larger impact on the dose accuracy than the precise geometrical
representation of the original CT and MR source images [64]. The observed e ect
of the bone stratification (fCT4 vs. fCT5 and fCT7 vs. fCT8) further indicates
the possible need either for the use of the pCT having two bone compartments
or the continuous density assigned to the bone label. Statistical regression with
continuous HU assignment has been previously identified as a promising method for
such voxel-based pCT generation [64].
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6 Conclusions
The presented work fulfilled the desired objectives. Flattened CT images serving as
the substitution for MR-based pCT were generated by employing 3D image processing
and segmentation methods. These images together with original CT volumes served
as the base for the extensive RT planning, and dose comparisons here reported. The
RT planning accuracy was assessed using two complementary standard methods
for dose comparison: DVH and gamma analysis. The most relevant results were
presented and further discussed in corresponding sections of this thesis.
The flattened CT version fCT5 with five tissue compartments excluding the
background air showed the best results for the employed patient cohort when viewed
in terms of dose accuracy alone. The fCT8 produced similar results as the fCT5
but with brain tissue also classified. This might be preferred by some clinical sites
due to the slightly better visual appearance. Both fCT5 and fCT8 were, therefore,
identified as the most appropriate tissue stratifications for the MR-only RT workflow
for brain tumour treatment.
All fCT versions showed a high dose calculation accuracy in the DVH analysis,
where even the di erence of 3% for fCTw could in some cases be claimed as su cient
for the safe use in radiotherapy. The gamma analysis, however, unveiled failures
caused by locally high HU di erences between fCT and CT images resulting from
insu cient tissue stratification. These observations have confirmed the need, earlier
identified by Edmund et. al (2014), for a measure putting together the correct
position and the right amount of a given tissue in pCT images [64]. The possible
candidate for such a measure was presented by Demol et. al (2016) who used the
modified gamma analysis replacing the dose di erence criterion by the HU intensity
di erence in the image voxel [50].
Even though the presented dose di erences between CT ad the fCT versions
are relatively small and the used gamma passing criterion is rather strict, we can
reasonably speculate that the importance of the correct tissue stratification may
possibly be larger when inaccuracies in the pCT due to MR-inherent distortions,
registration, positioning, and other errors are introduced by the real MR-only workflow.
Every single improvement in dose accuracy might thus play a fundamental role in
the development of a reliable and by all means safe MR-only RT solution for brain
tumour treatment.
A criterion for the safe use of MRI-only RT for brain tumour treatment was
suggested by Korsholm et al. (2014) as the PTV dose di erence less than 2% for 95%
of the patients compared to the CT-based dose calculation [5]. Although the number
of patients included in this study was not large enough for such considerations, small
di erences in the RT planning on CT and fCT images indicated that MR-only RT
planning for the brain is feasible with the pCT generated by bulk HU assignment to
MRI-derived tissue classification. This feasibility has been previously reported in
literature as well [5, 102]. Nevertheless, the entire MR-only workflow for brain consists
of many aspects that should be further investigated. These aspects are the impact of
surgery and, therefore, the presence of clips and incisions in the skull. The other
very important consideration is the patient positioning and the MR compatibility of
68
the positioning devices and their impact on the RT planning accuracy. These aspects
require further research.
69
References
[1] D. Andreasen, K. Van Leemput, R. H. Hansen, J. A. Andersen, and J. M. Ed-
mund, “Patch-based generation of a pseudo ct from conventional mri sequences
for mri-only radiotherapy of the bsrain,” Medical Physics, vol. 42, no. 4, pp.
1596–1605, 2015.
[2] J. Uh, T. E. Merchant, Y. Li, X. Li, and C. Hua, “Mri-based treatment
planning with pseudo ct generated through atlas registration,” Medical Physics,
vol. 41, no. 5, 2014, 051711.
[3] M. Hofmann, F. Steinke, V. Scheel, G. Charpiat, J. Farquhar, P. Ascho ,
M. Brady, B. Schölkopf, and B. J. Pichler, “Mri-based attenuation correction for
pet/mri: a novel approach combining pattern recognition and atlas registration,”
Journal of Nuclear Medicine, vol. 49, no. 11, pp. 1875–1883, 2008.
[4] C. Siversson, F. Nordström, T. Nilsson, T. Nyholm, J. Jonsson, A. Gunnlaugs-
son, and L. E. Olsson, “Technical note: Mri only prostate radiotherapy planning
using the statistical decomposition algorithm,” Medical Physics, vol. 42, no. 10,
pp. 6090–6097, 2015.
[5] M. E. Korsholm, L. W. Waring, and J. M. Edmund, “A criterion for the
reliable use of mri-only radiotherapy,” Radiation Oncology, vol. 9, no. 1, p. 16,
2014.
[6] J. H. Jonsson, M. M. Akhtari, M. G. Karlsson, A. Johansson, T. Asklund, and
T. Nyholm, “Accuracy of inverse treatment planning on substitute ct images
derived from mr data for brain lesions,” Radiation Oncology, vol. 10, no. 1,
p. 13, 2015.
[7] “Philips introduces first commercial mr-only solution for prostate cancer treat-
ment planning in the u.s. - news center | philips,” http://www.philips.com/a-
w/about/news/archive/standard/news/press/2016/20160331-philips-
introduces-first-commercial-mr-only-solution-for-prostate-cancer-treatment-
planning-in-the-us.html, (Accessed 2017-05-29).
[8] M. Köhler, T. Vaara, M. V. Grootel, R. Hoogeveen, R. Kemppainen, and
S. Renisch, “MR-only simulation for radiotherapy planning treatment planning,”
White Paper: Philips MRCAT for prostate dose calculations using only MRI
data, pp. 1–16, 2015. [Online]. Available: http://www.philips.co.uk/healthcare-
solutions/magnetic-resonance/therapy-systems (Accessed 2017-05-12).
[9] B. H. Kristensen, F. J. Laursen, V. Løgager, P. F. Geertsen, and A. Krarup-
Hansen, “Dosimetric and geometric evaluation of an open low-field magnetic
resonance simulator for radiotherapy treatment planning of brain tumours,”
Radiotherapy and Oncology, vol. 87, no. 1, pp. 100–109, 2008.
70
[10] T. Stanescu, H.-S. Jans, N. Pervez, P. Stavrev, and B. G. Fallone, “A study
on the magnetic resonance imaging (MRI)-based radiation treatment planning
of intracranial lesions,” Physics in Medicine and Biology, vol. 53, no. 13, pp.
3579–3593, Jul. 2008.
[11] “WHO | Cancer Key Facts.” [Online]. Available: http://www.who.int/cancer/
media/news/cancer-key-facts/en/ (Accessed 2017-05-12).
[12] J. Ferlay, E. Steliarova-Foucher, J. Lortet-Tieulent, S. Rosso, J. Coebergh,
H. Comber, D. Forman, and F. Bray, “Cancer incidence and mortality patterns
in europe: estimates for 40 countries in 2012,” European Journal of Cancer,
vol. 49, no. 6, pp. 1374–1403, 2013.
[13] D. N. Louis, A. Perry, G. Reifenberger, A. von Deimling, D. Figarella-Branger,
W. K. Cavenee, H. Ohgaki, O. D. Wiestler, P. Kleihues, and D. W. Ellison,
“The 2016 world health organization classification of tumors of the central
nervous system: a summary,” Acta Neuropathologica, vol. 131, no. 6, pp.
803–820, 2016.
[14] A. Barret, J. Dobbs, S. Morris, and T. Roques, “Practical radiotherapy plan-
ning,” 2009.
[15] H. Nazemi-Gelyan, H. Hasanzadeh, Y. Makhdumi, S. Abdollahi, F. Akbari,
F. Varshoee-Tabrizi, H. Almasrou, A. Nikoofar, and M. Rezaei-Tavirani, “Eval-
uation of organs at risk’s dose in external radiotherapy of brain tumors,” Iranian
Journal of Cancer Prevention, vol. 8, no. 1, pp. 47–52, 2015.
[16] J. H. Lee, Meningiomas: diagnosis, treatment, and outcome. Springer Science
& Business Media, 2008.
[17] S. Rahmani and L. S. Wong, “Central nerve system malignant tumors,” IOSR
Journal of Dental and Medical Sciences (IOSR-JDMS), vol. 1, no. 13, pp.
52–63, 2015.
[18] M. L. Bondy, M. E. Scheurer, B. Malmer, J. S. Barnholtz-Sloan, F. G. Davis,
D. Il’Yasova, C. Kruchko, B. J. McCarthy, P. Rajaraman, J. A. Schwartzbaum
et al., “Brain tumor epidemiology: consensus from the brain tumor epidemiology
consortium,” Cancer, vol. 113, no. S7, pp. 1953–1968, 2008.
[19] M. R. Gilbert, T. S. Armstrong, W. B. Pope, M. J. van den Bent, and
P. Y. Wen, “Facing the future of brain tumor clinical research,” Clinical
Cancer Research, vol. 20, no. 22, pp. 5591–5600, 2014. [Online]. Available:
https://doi.org/10.1158%2F1078-0432.ccr-14-0835 (Accessed 2017-05-12).
[20] V. Agrahari, “The exciting potential of nanotherapy in brain-tumor targeted
drug delivery approaches,” Neural Regeneration Research, vol. 12, no. 2, pp.
197–200, Feb. 2017.
71
[21] N. G. Burnet, S. J. Thomas, K. E. Burton, and S. J. Je eries, “Defining the
tumour and target volumes for radiotherapy,” Cancer Imaging, vol. 4, no. 2,
pp. 153–161, 2004.
[22] S.-H. Lu, J. C.-H. Cheng, S.-H. Kuo, J. J.-S. Lee, L.-H. Chen, J.-K. Wu,
Y.-H. Chen, W.-Y. Chen, S.-Y. Wen, F.-C. Chong et al., “Volumetric
modulated arc therapy for nasopharyngeal carcinoma: a dosimetric comparison
with tomotherapy and step-and-shoot imrt,” Radiotherapy and Oncology, vol.
104, no. 3, pp. 324–330, 2012.
[23] I. Rosenberg, “Radiation oncology physics: a handbook for teachers and
students,” British Journal of Cancer, vol. 98, no. 5, p. 1020, 2008.
[24] M. Kocher, A. Wittig, M. D. Piroth, H. Treuer, H. Seegenschmiedt, M. Ruge,
A.-L. Grosu, and M. Guckenberger, “Stereotactic radiosurgery for treatment of
brain metastases,” Strahlentherapie und Onkologie, vol. 190, no. 6, pp. 521–532,
2014.
[25] F. M. Khan and J. P. Gibbons, Khan’s the physics of radiation therapy.
Lippincott Williams & Wilkins, 2014.
[26] P. Mayles and J.-C. Rosenwald, “Radiation protection in radiotherapy,” in
Handbook of Radiotherapy Physics: Theory and Practice. Taylor & Francis,
2007, pp. 1229–1232.
[27] S. Scoccianti, B. Detti, D. Gadda, D. Greto, I. Furfaro, F. Meacci, G. Simontac-
chi, L. Di Brina, P. Bonomo, I. Giacomelli et al., “Organs at risk in the brain
and their dose-constraints in adults and in children: a radiation oncologist’s
guide for delineation in everyday practice,” Radiotherapy and Oncology, vol.
114, no. 2, pp. 230–238, 2015.
[28] A. Isambert, F. Dhermain, F. Bidault, O. Commowick, P.-Y. Bondiau, G. Ma-
landain, and D. Lefkopoulos, “Evaluation of an atlas-based automatic segmen-
tation software for the delineation of brain organs at risk in a radiation therapy
clinical context,” Radiotherapy and Oncology, vol. 87, no. 1, pp. 93–99, 2008.
[29] X. Sun, S. Su, C. Chen, F. Han, C. Zhao, W. Xiao, X. Deng, S. Huang, C. Lin,
and T. Lu, “Long-term outcomes of intensity-modulated radiotherapy for 868
patients with nasopharyngeal carcinoma: an analysis of survival and treatment
toxicities,” Radiotherapy and Oncology, vol. 110, no. 3, pp. 398–403, 2014.
[30] A. Dunlop, L. Welsh, D. McQuaid, J. Dean, S. Gulliford, V. Hansen, S. Bhide,
C. Nutting, K. Harrington, and K. Newbold, “Brain-sparing methods for imrt
of head and neck cancer,” PLoS ONE, vol. 10, no. 3, 2015, e0120141.
[31] “Image Gallery | Varian Medical Systems.” [Online]. Available: http:
//newsroom.varian.com/Edge (Accessed 2017-05-12).
72
[32] V. Feygelman, D. Hunt, L. Walker, R. Mueller, M. L. Demarco, T. Dilling,
C. Stevens, and G. Zhang, “Validation of pinnacle treatment planning system
for use with novalis delivery unit,” Journal of Applied Clinical Medical Physics,
vol. 11, no. 3, pp. 135–153, 2010.
[33] E. H. Lin, M. Von Kor , D. Peterson, E. J. Ludman, P. Ciechanowski, and
W. Katon, “Population targeting and durability of multimorbidity collaborative
care management,” The American Journal of Managed Care, vol. 20, no. 11,
pp. 887–895, 2014.
[34] A. Pugachev, J. G. Li, A. L. Boyer, S. L. Hancock, Q.-T. Le, S. S. Donaldson,
and L. Xing, “Role of beam orientation optimization in intensity-modulated
radiation therapy,” International Journal of Radiation Oncology* Biology*
Physics, vol. 50, no. 2, pp. 551–560, 2001.
[35] J. Sta urth et al., “A review of the clinical evidence for intensity-modulated
radiotherapy,” Clinical Oncology, vol. 22, no. 8, pp. 643–657, 2010.
[36] M. Teoh, C. H. Clark, K. Wood, S. Whitaker, and A. Nisbet, “Volumetric
modulated arc therapy: a review of current literature and clinical use in
practice,” The British Journal of Radiology, vol. 84, no. 1007, pp. 967–996,
2011, pMID: 22011829.
[37] G. Smyth, J. C. Bamber, P. M. Evans, and J. L. Bedford, “Trajectory
optimization for dynamic couch rotation during volumetric modulated arc
radiotherapy,” Physics in Medicine and Biology, vol. 58, no. 22, pp. 8163–8177,
2013.
[38] Y. Jeong, S.-w. Lee, J. Kwak, I. Cho, S. M. Yoon, J. H. Kim, J.-h. Park,
E. K. Choi, S. Y. Song, Y. S. Kim, S. S. Kim, J. H. Joo, and S. D. Ahn,
“A dosimetric comparison of volumetric modulated arc therapy (vmat) and
non-coplanar intensity modulated radiotherapy (imrt) for nasal cavity and
paranasal sinus cancer,” Radiation Oncology, vol. 9, no. 1, p. 193, 2014.
[39] V. Panet-Raymond, W. Ansbacher, S. Zavgorodni, B. Bendor e, A. Nichol,
P. T. Truong, W. Beckham, and M. Vlachaki, “Coplanar versus noncoplanar
intensity-modulated radiation therapy (imrt) and volumetric-modulated arc
therapy (vmat) treatment planning for fronto-temporal high-grade glioma,”
Journal of Applied Clinical Medical Physics, vol. 13, no. 4, 2012, s832.
[40] D. Nguyen, J.-C. M. Rwigema, V. Y. Yu, T. Kaprealian, P. Kupelian, M. Selch,
P. Lee, D. A. Low, and K. Sheng, “Feasibility of extreme dose escalation for
glioblastoma multiforme using 4fi radiotherapy,” Radiation Oncology, vol. 9,
no. 1, p. 239, 2014.
[41] R. Sha er, A. M. Nichol, E. Vollans, M. Fong, S. Nakano, V. Moiseenko,
M. Schmuland, R. Ma, M. McKenzie, and K. Otto, “A comparison of volumetric
modulated arc therapy and conventional intensity-modulated radiotherapy for
73
frontal and temporal high-grade gliomas,” International Journal of Radiation
Oncology* Biology* Physics, vol. 76, no. 4, pp. 1177–1184, 2010.
[42] G. Smyth, P. M. Evans, J. C. Bamber, H. C. Mandeville, L. C. Welsh, F. H.
Saran, and J. L. Bedford, “Non-coplanar trajectories to improve organ at
risk sparing in volumetric modulated arc therapy for primary brain tumors,”
Radiotherapy and Oncology, vol. 121, no. 1, pp. 124–131, 2016.
[43] J. M. Edmund and T. Nyholm, “A review of substitute ct generation for
mri-only radiation therapy,” Radiation Oncology, vol. 12, no. 1, p. 28, 2017.
[44] M. C. Mesias, J. Boda-Heggemann, J. Thoelking, F. Lohr, F. Wenz, and
H. Wertz, “Quantification and assessment of interfraction setup errors based
on cone beam ct and determination of safety margins for radiotherapy,” PLoS
ONE, vol. 11, no. 3, 2016, e0150326.
[45] S. G. Soltys, J. P. Kirkpatrick, N. N. Laack, B. D. Kavanagh, J. C. Breneman,
and H. A. Shih, “Is less, more? the evolving role of radiation therapy for brain
metastases,” International Journal of Radiation Oncology• Biology• Physics,
vol. 92, no. 5, pp. 963–966, 2015.
[46] T. Nyholm, M. Nyberg, M. G. Karlsson, and M. Karlsson, “Systematisation of
spatial uncertainties for comparison between a mr and a ct-based radiotherapy
workflow for prostate treatments,” Radiation Oncology, vol. 4, no. 1, p. 54,
2009.
[47] S.-H. Hsu, Y. Cao, K. Huang, M. Feng, and J. M. Balter, “Investigation of a
method for generating synthetic CT models from MRI scans of the head and
neck for radiation therapy,” Physics in Medicine and Biology, vol. 58, no. 23,
pp. 8419–8435, 2013.
[48] J. Sjölund, D. Forsberg, M. Andersson, and H. Knutsson, “Generating patient
specific pseudo-CT of the head from MR using atlas-based regression,” Physics
in Medicine and Biology, vol. 60, no. 2, pp. 825–839, 2015.
[49] B. K. Navalpakkam, H. Braun, T. Kuwert, and H. H. Quick, “Magnetic
resonance–based attenuation correction for pet/mr hybrid imaging using con-
tinuous valued attenuation maps,” Investigative Radiology, vol. 48, no. 5, pp.
323–332, 2013.
[50] B. Demol, C. Boydev, J. Korhonen, and N. Reynaert, “Dosimetric characteriza-
tion of mri-only treatment planning for brain tumors in atlas-based pseudo-ct
images generated from standard t1-weighted mr images,” Medical Physics,
vol. 43, no. 12, pp. 6557–6568, 2016.
[51] M. S. R. Gudur, W. Hara, Q.-T. Le, L. Wang, L. Xing, and R. Li, “A
unifying probabilistic Bayesian approach to derive electron density from MRI
for radiation therapy treatment planning,” Physics in Medicine and Biology,
vol. 59, no. 21, pp. 6595–6606, 2014.
74
[52] J. Rahmer, U. Blume, and P. Börnert, “Selective 3d ultrashort te imaging:
comparison of “dual-echo” acquisition and magnetization preparation for im-
proving short-t 2 contrast,” Magnetic Resonance Materials in Physics, Biology
and Medicine, vol. 20, no. 2, pp. 83–92, 2007.
[53] F. Wiesinger, L. I. Sacolick, A. Menini, S. S. Kaushik, S. Ahn, P. Veit-
Haibach, G. Delso, and D. D. Shanbhag, “Zero te mr bone imaging in the
head,” Magnetic Resonance in Medicine, vol. 75, no. 1, pp. 107–114, 2016.
[54] V. Keereman, Y. Fierens, T. Broux, Y. De Deene, M. Lonneux, and S. Vanden-
berghe, “Mri-based attenuation correction for pet/mri using ultrashort echo
time sequences,” Journal of Nuclear Medicine, vol. 51, no. 5, pp. 812–818,
2010.
[55] C. M. Rank, C. Tremmel, N. Hünemohr, A. M. Nagel, O. Jäkel, and S. Greilich,
“Mri-based treatment plan simulation and adaptation for ion radiotherapy using
a classification-based approach,” Radiation Oncology, vol. 8, no. 1, p. 51, 2013.
[56] R. Acosta, M. Ehrgott, A. Holder, D. Nevin, J. Reese, and B. Salter, The
influence of dose grid resolution on beam selection strategies in radiotherapy
treatment design. New York, NY: Springer New York, 2008, pp. 1–23.
[57] D. A. Low, W. B. Harms, S. Mutic, and J. A. Purdy, “A technique for the
quantitative evaluation of dose distributions,” Medical Physics, vol. 25, no. 5,
pp. 656–661, 1998.
[58] J. Winiecki, T. Morgaú, K. Majewska, and B. Drzewiecka, “The gamma
evaluation method as a routine qa procedure of imrt,” Reports of Practical
Oncology & Radiotherapy, vol. 14, no. 5, pp. 162–168, 2009.
[59] J.-H. Song, M.-J. Kim, S.-H. Park, S.-R. Lee, M.-Y. Lee, D. S. Lee, and T. S.
Suh, “Gamma analysis dependence on specified low-dose thresholds for vmat
qa,” Journal of Applied Clinical Medical Physics, vol. 16, no. 6, pp. 263–272,
2015.
[60] K. Ulin, M. M. Urie, and J. M. Cherlow, “Results of a multi-institutional
benchmark test for cranial ct/mr image registration,” International Journal of
Radiation Oncology* Biology* Physics, vol. 77, no. 5, pp. 1584–1589, 2010.
[61] G. M. Cattaneo, M. Reni, G. Rizzo, P. Castellone, G. L. Ceresoli, C. Cozzarini,
A. J. M. Ferreri, P. Passoni, and R. Calandrino, “Target delineation in post-
operative radiotherapy of brain gliomas: interobserver variability and impact
of image registration of mr (pre-operative) images on treatment planning ct
scans,” Radiotherapy and Oncology, vol. 75, no. 2, pp. 217–223, 2005.
[62] G. Minniti, E. Clarke, G. Lanzetta, M. F. Osti, G. Trasimeni, A. Bozzao,
A. Romano, and R. M. Enrici, “Stereotactic radiosurgery for brain metastases:
analysis of outcome and risk of brain radionecrosis,” Radiation Oncology, vol. 6,
no. 1, p. 48, 2011.
75
[63] J.-F. Daisne, M. Sibomana, A. Bol, T. Doumont, M. Lonneux, and V. Grégoire,
“Tri-dimensional automatic segmentation of pet volumes based on measured
source-to-background ratios: influence of reconstruction algorithms,” Radio-
therapy and Oncology, vol. 69, no. 3, pp. 247–250, 2003.
[64] J. M. Edmund, H. M. Kjer, K. Van Leemput, R. H. Hansen, J. A. Andersen,
and D. Andreasen, “A voxel-based investigation for MRI-only radiotherapy
of the brain using ultra short echo times,” Physics in Medicine and Biology,
vol. 59, no. 23, pp. 7501–7519, Dec. 2014.
[65] E. Paradis, Y. Cao, T. S. Lawrence, C. Tsien, M. Feng, K. Vineberg, and J. M.
Balter, “Assessing the dosimetric accuracy of magnetic resonance-generated
synthetic ct images for focal brain vmat radiation therapy,” International
Journal of Radiation Oncology* Biology* Physics, vol. 93, no. 5, pp. 1154–1161,
2015.
[66] T. Layer, M. Blaickner, B. Knäusl, D. Georg, J. Neuwirth, R. P. Baum,
C. Schuchardt, S. Wiessalla, and G. Matz, “Pet image segmentation using a
gaussian mixture model and markov random fields,” EJNMMI Physics, vol. 2,
no. 1, p. 9, 2015.
[67] M. Van Herk, “Errors and margins in radiotherapy,” in Seminars in Radiation
Oncology, vol. 14, no. 1. Elsevier, 2004, pp. 52–64.
[68] F. Dhermain, “Radiotherapy of high-grade gliomas: current standards and
new concepts, innovations in imaging and radiotherapy, and new therapeutic
approaches,” Chinese Journal of Cancer, vol. 33, no. 1, pp. 16–24, jan 2014.
[69] J. F. Barrett and N. Keat, “Artifacts in ct: Recognition and avoidance,”
RadioGraphics, vol. 24, no. 6, pp. 1679–1691, 2004, pMID: 15537976.
[70] A. Fedorov, R. Beichel, J. Kalpathy-Cramer, J. Finet, J.-C. Fillion-Robin,
S. Pujol, C. Bauer, D. Jennings, F. Fennessy, M. Sonka, J. Buatti, S. Aylward,
J. V. Miller, S. Pieper, and R. Kikinis, “3D Slicer as an Image Computing
Platform for the Quantitative Imaging Network,” Magnetic Resonance Imaging,
vol. 30, no. 9, pp. 1323–1341, nov 2012.
[71] E. R. Dougherty and R. A. Lotufo, Hands-on morphological image processing.
SPIE press, 2003, vol. 59.
[72] M. N. Favorskaya, L. C. Jain et al., Computer Vision in Control Systems-1.
Springer, 2015.
[73] “File:Dylatacja przyklad.png - Wikimedia Commons.” [Online]. Available:
https://commons.wikimedia.org/wiki/File:Dylatacja_przyklad.png (Accessed
2017-05-12).
76
[74] “File:Erozja przyklad.png - Wikimedia Commons.” [Online]. Available:
https://commons.wikimedia.org/wiki/File:Erozja_przyklad2.png (Accessed
2017-05-12).
[75] “File:Two-pass connected component labeling.png - Wikimedia Commons.”
[Online]. Available: https://commons.wikimedia.org/wiki/File:Two-pass_
connected_component_labeling.png (Accessed 2017-05-12).
[76] M. Kass, A. Witkin, and D. Terzopoulos, “Snakes: Active contour models,”
International Journal of Computer Vision, vol. 1, no. 4, pp. 321–331, 1988.
[77] H. Nakano, K. Mishima, Y. Ueda, A. Matsushita, H. Suga, Y. Miyawaki,
T. Mano, Y. Mori, and Y. Ueyama, “A new method for determining the optimal
ct threshold for extracting the upper airway,” Dentomaxillofacial Radiology,
vol. 42, no. 3, pp. 2639–7438, 2013, pMID: 22842640.
[78] W. Narkbuakaew, H. Nagahashi, K. Aoki, and Y. Kubota, “Bone segmentation
in ct-liver images using k-means clustering for 3d rib cage surface-modeling,”
WSEAS Transactions on Biology and Biomedicine, vol. 11, pp. 183–193, 2014.
[79] M. Y. Mashor, “Improving the performance of k-means clustering algorithm
to position the centers of rbf network,” International Journal of the Computer,
The Internet and Management, vol. 6, no. 2, pp. 121–124, 1998.
[80] D. Arthur and S. Vassilvitskii, “k-means++: The advantages of careful seeding,”
in Proceedings of the eighteenth annual ACM-SIAM symposium on Discrete
algorithms. Society for Industrial and Applied Mathematics, 2007, pp. 1027–
1035.
[81] P. J. Rousseeuw, “Silhouettes: a graphical aid to the interpretation and valida-
tion of cluster analysis,” Journal of Computational and Applied Mathematics,
vol. 20, pp. 53–65, 1987.
[82] N. J. Tustison and J. Gee, “N4itk: Nick’s n3 itk implementation for mri bias
field correction,” Insight Journal, Dec. 2010.
[83] K. Held, E. R. Kops, B. J. Krause, W. M. Wells, R. Kikinis, and H.-W.
Muller-Gartner, “Markov random field segmentation of brain mr images,” IEEE
Transactions on Medical Imaging, vol. 16, no. 6, pp. 878–886, 1997.
[84] K. Ohtakara, S. Hayashi, H. Tanaka, and H. Hoshi, “Consideration of optimal
isodose surface selection for target coverage in micro-multileaf collimator-based
stereotactic radiotherapy for large cystic brain metastases: comparison of 90%,
80% and 70% isodose surface-based planning,” The British Journal of Radiology,
vol. 85, no. 1017, pp. e640–e646, 2012, pMID: 22422384.
[85] J. L. Robar and C. Thomas, “Hybridarc: a novel radiation therapy tech-
nique combining optimized dynamic arcs and intensity modulation,” Medical
Dosimetry, vol. 37, no. 4, pp. 358–368, 2013.
77
[86] M. Rao, W. Yang, F. Chen, K. Sheng, J. Ye, V. Mehta, D. Shepard, and
D. Cao, “Comparison of elekta vmat with helical tomotherapy and fixed field
imrt: plan quality, delivery e ciency and accuracy,” Medical Physics, vol. 37,
no. 3, pp. 1350–1359, 2010.
[87] “Accelerated IMRT and VMAT planning,” Philips White Paper, pp. 1–4,
2014. [Online]. Available: http://incenter.medical.philips.com/doclib/
enc/fetch/2000/4504/577242/577243/577244/582095/582189/Pinnacle3_
AutoPlanning_Overview.pdf%3fnodeid%3d10689140%26vernum%3d-2
(Accessed 2017-05-12).
[88] K. Bzdusek, H. Friberger, K. Eriksson, B. Hårdemark, D. Robinson, and
M. Kaus, “Development and evaluation of an e cient approach to volumetric
arc therapy planning,” Medical Physics, vol. 36, no. 6, pp. 2328–2339, 2009.
[89] J. C. Marsh, G. E. Ziel, A. Z. Diaz, J. A. Wendt, R. Gobole, and J. V.
Turian, “Integral dose delivered to normal brain with conventional intensity-
modulated radiotherapy (imrt) and helical tomotherapy imrt during partial
brain radiotherapy for high-grade gliomas with and without selective sparing of
the hippocampus, limbic circuit and neural stem cell compartment,” Journal
of Medical Imaging and Radiation Oncology, vol. 57, no. 3, pp. 378–383, 2013.
[90] M. Farzin, M. Molls, S. Astner, I.-C. Rondak, and M. Oechsner, “Simultaneous
integrated vs. sequential boost in vmat radiotherapy of high-grade gliomas,”
Strahlentherapie und Onkologie, vol. 191, no. 12, pp. 945–952, 2015.
[91] T. McNutt, “Dose calculations: collapsed cone convolution superposition and
delta pixel beam,” Philips White Paper, no. 4535, p. 983, 2002.
[92] M. Wendling, L. J. Zijp, L. N. McDermott, E. J. Smit, J.-J. Sonke, B. J.
Mijnheer, and M. van Herk, “A fast algorithm for gamma evaluation in 3d,”
Medical Physics, vol. 34, no. 5, pp. 1647–1654, 2007.
[93] M. Janaszewski, M. Couprie, and L. Babout, “Hole filling in 3d volumetric
objects,” Pattern Recognition, vol. 43, no. 10, pp. 3548–3559, 2010.
[94] L. D. Cohen, “On active contour models and balloons,” CVGIP: Image
Understanding, vol. 53, no. 2, pp. 211–218, 1991.
[95] J. Sachdeva, V. Kumar, I. Gupta, N. Khandelwal, and C. K. Ahuja, “A novel
content-based active contour model for brain tumor segmentation,” Magnetic
Resonance Imaging, vol. 30, no. 5, pp. 694–715, 2012.
[96] X. Qian, J. Wang, S. Guo, and Q. Li, “An active contour model for medical
image segmentation with application to brain ct image,” Medical Physics,
vol. 40, no. 2, 2013, 021911.
78
[97] N. L. Bui, S. H. Ong, and K. W. C. Foong, “Automatic segmentation of the
nasal cavity and paranasal sinuses from cone-beam ct images,” International
Journal of Computer Assisted Radiology and Surgery, vol. 10, no. 8, pp. 1269–
1277, 2015.
[98] R. Widita and O. Ivansyah, “Image Segmentation Of CT Head
Image To Define Tumour Using K-Means Clustering Algorithm,” IOSR
Journal of Applied Physics, vol. 8, no. 2, pp. 29–31, 2016. [Online].
Available: http://www.iosrjournals.org/iosr-jap/papers/Vol8-issue2/Version-
1/F0802012931.pdf (Accessed 2017-05-26).
[99] M. van Eijnatten, J. Koivisto, K. Karhu, T. Forouzanfar, and J. Wol , “The
impact of manual threshold selection in medical additive manufacturing,” In-
ternational Journal of Computer Assisted Radiology and Surgery, pp. 1–9,
2016.
[100] A. Nejati, N. Kabaliuk, M. C. Jermy, and J. E. Cater, “A deformable template
method for describing and averaging the anatomical variation of the human
nasal cavity,” BMC Medical Imaging, vol. 16, no. 1, p. 55, 2016.
[101] Z. Kato and T.-C. Pong, A Markov Random Field Image Segmentation Model
Using Combined Color and Texture Features. Berlin, Heidelberg: Springer
Berlin Heidelberg, 2001, pp. 547–554.
[102] J. H. Jonsson, M. G. Karlsson, M. Karlsson, and T. Nyholm, “Treatment
planning using mri data: an analysis of the dose calculation accuracy for
di erent treatment regions,” Radiation Oncology, vol. 5, no. 1, p. 62, 2010.
[103] J. Korhonen, M. Kapanen, J. Keyriläinen, T. Seppälä, and M. Tenhunen, “A
dual model hu conversion from mri intensity values within and outside of bone
segment for mri-based radiotherapy treatment planning of prostate cancer,”
Medical Physics, vol. 41, no. 1, 2014, 011704.
[104] I. C. on Radiation Units and Measurements, Photon, Electron, Proton, and
Neutron Interaction Data for Body Tissues, ser. American Fisheries Society
Symposium. International Commission on Radiation Units and Measurements,
1992.
